Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Requirement of pp60c-src expression for osteoclasts to form ruffled borders and resorb bone in mice.
B F Boyce, … , P Soriano, G R Mundy
B F Boyce, … , P Soriano, G R Mundy
Published October 1, 1992
Citation Information: J Clin Invest. 1992;90(4):1622-1627. https://doi.org/10.1172/JCI116032.
View: Text | PDF
Research Article Article has an altmetric score of 3

Requirement of pp60c-src expression for osteoclasts to form ruffled borders and resorb bone in mice.

  • Text
  • PDF
Abstract

Targeted disruption of the c-src proto-oncogene in mice has shown that src expression is required for normal bone resorption, since the src-deficient mutants develop osteopetrosis. To evaluate the mechanisms by which src-deficiency affects osteoclast function, we treated src-deficient mice with the stimulants of bone resorption, IL-1, parathyroid hormone, and parathyroid hormone-related protein, and analyzed the effects by quantitative bone histomorphometry and electron microscopy. Increased numbers of multinucleated cells with the morphological characteristics of osteoclasts appeared on bone surfaces, but these cells did not form ruffled borders or normal resorption lacunae. To confirm these in vivo findings, we cultured src-mutant bone marrow cells on dentine slices in the presence of 1,25 dihydroxyvitamin D3. Increased numbers of multinucleated cells were formed, but unlike normal murine bone marrow cells, they did not form resorption pits. These results indicate that osteoclasts appear in the absence of pp60c-src, but that pp60c-src expression is required for mature osteoclasts to form ruffled borders and resorb bone.

Authors

B F Boyce, T Yoneda, C Lowe, P Soriano, G R Mundy

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1965 Total
Citations: 3 2 2 2 8 6 8 13 12 8 8 13 12 17 17 32 14 18 13 21 22 18 16 11 19 32 20 25 17 21 11 7 7 1 456
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (456)

Title and authors Publication Year
Extracellular matrix: Dystroglycan interactions—Roles for the dystrophin‐associated glycoprotein complex in skeletal tissue dynamics
Hopkinson M, Pitsillides AA
International Journal of Experimental Pathology 2025
Exploring the mechanisms and targets of proton pump inhibitors-induced osteoporosis through network toxicology, molecular docking, and molecular dynamics simulations
Mu Y, Zhou Y, Zhang X, Shao Y
Frontiers in Pharmacology 2025
Formation of Membrane Domains via Actin Waves: A Fundamental Principle in the Generation of Dynamic Structures in Phagocytes
Takito J, Nonaka N
International Journal of Molecular Sciences 2025
Unraveling the intricacies of osteoclast differentiation and maturation: insight into novel therapeutic strategies for bone-destructive diseases.
Takegahara N, Kim H, Choi Y
Experimental & molecular medicine 2024
Biomaterial Cues for Regulation of Osteoclast Differentiation and Function in Bone Regeneration
Shariati K, Bedar M, Huang KX, Moghadam S, Mirzaie S, LaGuardia JS, Chen W, Kang Y, Ren X, Lee JC
Advanced therapeutics 2024
Suppressive effects of (-)-tubaic acid on RANKL-induced osteoclast differentiation and bone resorption.
Lim S, Ihn HJ, Kim JA, Bae JS, Kim JE, Bae YC, Shin HI, Kim TH, Park EK
Animal Cells and Systems 2023
Functional roles of SRC signaling in pancreatic cancer: Recent insights provide novel therapeutic opportunities.
Poh AR, Ernst M
Oncogene 2023
Tyrosine Kinase Src Is a Regulatory Factor of Bone Homeostasis
Matsubara T, Yasuda K, Mizuta K, Kawaue H, Kokabu S
International journal of molecular sciences 2022
Metastasis suppressor 1 controls osteoblast differentiation and bone homeostasis through regulating Src-Wnt/β-catenin signaling
Chen M, Shan L, Gan Y, Tian L, Zhou J, Zhu E, Yuan H, Li X, Wang B
2022
Protein phosphatase 1 regulatory subunit 18 suppresses the transcriptional activity of NFATc1 via regulation of c-fos
K Yasuda, T Matsubara, T Shirakawa, T Kawamoto, S Kokabu
Bone Reports 2021
Regulation of TNF-Induced Osteoclast Differentiation
Z Yao, S Getting, I Locke
Cells 2021
Tetraspanin 7 regulates osteoclast function through association with the RANK/αvβ3 integrin complex
M Kim, J Lin, JE Huh, JH Park, M Go, H Lee, D Hwang, HS Kim, T Kim, D Lee, SY Lee
Journal of Cellular Physiology 2021
Characterization of unique functionalities in c-Src domains required for osteoclast podosome belt formation
T Matsubara, WN Addison, S Kokabu, L Neff, W Horne, F Gori, R Baron
The Journal of biological chemistry 2021
Novel Majeed Syndrome–Causing LPIN2 Mutations Link Bone Inflammation to Inflammatory M2 Macrophages and Accelerated Osteoclastogenesis
F Bhuyan, AA Jesus, J Mitchell, E Leikina, R VanTries, R Herzog, KB Onel, A Oler, GA Sanchez, KA Johnson, L Bichell, B Marrero, LF Castro, Y Huang, KR Calvo, MT Collins, S Ganesan, LV Chernomordik, PJ Ferguson, R GoldbachMansky
Arthritis & Rheumatology 2021
Two macrophages, osteoclasts and microglia: from development to pleiotropy
JW Lee, IH Lee, T Iimura, SW Kong
Bone Research 2021
Beclin 1 positively regulates osteoprotegerin-induced inhibition of osteoclastogenesis by increasing autophagy in vitro
X Tong, W Min, S Li, M Chen, R Song, J Bian, J Gu, Z Liu
Differentiation; research in biological diversity 2021
Flavonoids: Classification, Function, and Molecular Mechanisms Involved in Bone Remodelling
P Ramesh, R Jagadeesan, S Sekaran, A Dhanasekaran, S Vimalraj
Frontiers in Endocrinology 2021
Hdac3 deletion in myeloid progenitor cells enhances bone healing in females and limits osteoclast fusion via Pmepa1
DH Molstad, E Zars, A Norton, KC Mansky, JJ Westendorf, EW Bradley
Scientific Reports 2020
Osteoclast Signal Transduction During Bone Metastasis Formation
DS Győri, A Mócsai
Frontiers in Cell and Developmental Biology 2020
PP121 suppresses RANKL-Induced osteoclast formation in vitro and LPS-Induced bone resorption in vivo
Z Zhou, X Chen, X Chen, A Qin, Y Mao, Y Pang, S Yu, S Zhang
Experimental Cell Research 2020
Targeting anti-cancer agents to bone using bisphosphonates
L Xing, FH Ebetino, RK Boeckman, V Srinivasan, J Tao, TK Sawyer, J Li, Z Yao, BF Boyce
Bone 2020
Plectin stabilizes microtubules during osteoclastic bone resorption by acting as a scaffold for Src and Pyk2
T Matsubara, T Yaginuma, WN Addison, Y Fujita, K Watanabe, I Yoshioka, H Hikiji, K Maki, R Baron, S Kokabu
Bone 2020
Cytoplasmic PCNA is located in the actin belt and involved in osteoclast differentiation
D Tang, X Liu, K Chen, Z Li, Y Dai, J Xu, HT Zhang, X Gao, L Liu
Aging 2020
The osteoclast, a target cell for microorganisms
B Raynaud-Messina, C Verollet, I Maridonneau-Parini
Bone 2019
RNA-based therapy for osteogenesis
P Wang, F Perche, D Logeart-Avramoglou, C Pichon
International Journal of Pharmaceutics 2019
RACK1 interaction with c-Src is essential for osteoclast function
JH Park, E Jeong, J Lin, R Ko, JH Kim, S Yi, Y Choi, IC Kang, D Lee, SY Lee
Experimental & molecular medicine 2019
CD55 Regulates Bone Mass in Mice by Modulating RANKL‐Mediated Rac Signaling and Osteoclast Function
B Shin, H Won, DJ Adams, SK Lee
Journal of Bone and Mineral Research 2019
Deficiency in the phosphatase PHLPP1 suppresses osteoclast-mediated bone resorption and enhances bone formation in mice
AM Mattson, DL Begun, DH Molstad, MA Meyer, MJ Oursler, JJ Westendorf, EW Bradley
The Journal of biological chemistry 2019
Alveolar Bone Protection by Targeting the SH3BP2‐SYK Axis in Osteoclasts
M Kittaka, T Yoshimoto, C Schlosser, R Rottapel, M Kajiya, H Kurihara, EJ Reichenberger, Y Ueki
Journal of Bone and Mineral Research 2019
Kif1c regulates osteoclastic bone resorption as a downstream molecule of p130Cas
M Kobayakawa, T Matsubara, A Mizokami, F Hiura, N Takakura, S Kokabu, M Matsuda, H Yasuda, I Nakamura, Y Takei, H Honda, R Hosokawa, E Jimi
Cell Biochemistry and Function 2019
Atlas of Immediate Dental Implant Loading
M Peñarrocha-Diago, U Covani, L Cuadrado
2019
Updating osteoimmunology: regulation of bone cells by innate and adaptive immunity
MC Walsh, N Takegahara, H Kim, Y Choi
Nature Reviews Rheumatology 2018
Recent advances in osteoclast biology
T Ono, T Nakashima
Histochemistry and Cell Biology 2018
Rab GTPases in Osteoclastic Endomembrane Systems
M Roy, S Roux
BioMed Research International 2018
Non-canonical Wnt signals regulate cytoskeletal remodeling in osteoclasts
S Uehara, N Udagawa, Y Kobayashi
Cellular and Molecular Life Sciences 2018
c-Src–Dependent and –Independent Functions of Matk in Osteoclasts and Osteoblasts
JH Kim, K Kim, I Kim, S Seong, N Kim
Journal of immunology (Baltimore, Md. : 1950) 2018
Systemic Activation of Activin A Signaling Causes Chronic Kidney Disease-Mineral Bone Disorder
T Sugatani
International journal of molecular sciences 2018
A novel miR17 /protein tyrosine phosphatase-oc/EphA4 regulatory axis of osteoclast activity
KH Lau, MH Sheng
Archives of Biochemistry and Biophysics 2018
Selective inhibition of Src family kinases by SU6656 increases bone mass by uncoupling bone formation from resorption in mice
C Thouverey, S Ferrari, J Caverzasio
Bone 2018
Raddeanin A suppresses breast cancer-associated osteolysis through inhibiting osteoclasts and breast cancer cells
Q Wang, J Mo, C Zhao, K Huang, M Feng, W He, J Wang, S Chen, Z Xie, J Ma, S Fan
Cell Death and Disease 2018
Myosins in Osteoclast Formation and Function
B Lee
Biomolecules 2018
Identification of N-(5-(phenoxymethyl)-1,3,4-thiadiazol-2-yl)acetamide derivatives as novel protein tyrosine phosphatase epsilon inhibitors exhibiting anti-osteoclastic activity
B Ku, HY Yun, KW Lee, HC Shin, SR Lee, CH Kim, H Park, KY Yi, CH Lee, SJ Kim
Bioorganic & Medicinal Chemistry 2018
Bone-Fracture-Targeted Dasatinib-Oligoaspartic Acid Conjugate Potently Accelerates Fracture Repair
M Wang, S Park, Y Nam, J Nielsen, SA Low, M Srinivasarao, PS Low
Bioconjugate Chemistry 2018
The Sealing Zone in Osteoclasts: A Self-Organized Structure on the Bone.
Takito J, Inoue S, Nakamura M
International journal of molecular sciences 2018
RNF146 is an Osteoclastogenic Switch Regulated by RANK Ligand
Yoshinori Matsumoto, Jose La Rose, Oliver A. Kent, Melissa Lim, Adele Changoor, Lucia Zhang, Yaryna Storozhuk, Xiaohong Mao, Marc Grynpas, Feng Cong, Robert Rottapel
Journal of Clinical Investigation 2017
Protein kinase N3 promotes bone resorption by osteoclasts in response to Wnt5a-Ror2 signaling
S Uehara, N Udagawa, H Mukai, A Ishihara, K Maeda, T Yamashita, K Murakami, M Nishita, T Nakamura, S Kato, Y Minami, N Takahashi, Y Kobayashi
Science signaling 2017
RON kinase: A target for treatment of cancer-induced bone destruction and osteoporosis
K Andrade, J Fornetti, L Zhao, SC Miller, RL Randall, N Anderson, SE Waltz, M McHale, AL Welm
Science Translational Medicine 2017
The Biology of Bone Metastasis
M Esposito, T Guise, Y Kang
Cold Spring Harbor Perspectives in Medicine 2017
The Actin-Binding Protein PPP1r18 Regulates Maturation, Actin Organization, and Bone Resorption Activity of Osteoclasts
T Matsubara, S Kokabu, C Nakatomi, M Kinbara, T Maeda, M Yoshizawa, H Yasuda, T Takano-Yamamoto, R Baron, E Jimi
Molecular and cellular biology 2017
Small non-coding RNAs-based bone regulation and targeting therapeutic strategies
Y Yang, S Fang
Molecular and Cellular Endocrinology 2017
Histochemical assessment for osteoblastic activity coupled with dysfunctional osteoclasts in c-src deficient mice
H TORAY, T HASEGAWA, N SAKAGAMI, E TSUCHIYA, A KUDO, S ZHAO, Y MORITANI, M ABE, T YOSHIDA, T YAMAMOTO, T YAMAMOTO, K ODA, N UDAGAWA, PH de FREITAS, M LI
Biomedical Research 2017
Regulation of osteoclast differentiation and actin ring formation by the cytolinker protein plectin
T Matsubara, M Kinbara, T Maeda, M Yoshizawa, S Kokabu, TT Yamamoto
Biochemical and Biophysical Research Communications 2017
Clinical Aspects of Natural and Added Phosphorus in Foods
OM Gutiérrez, K Kalantar-Zadeh, R Mehrotra
Clinical Aspects of Natural and Added Phosphorus in Foods 2017
Promotion of Tumor Invasion by Tumor-Associated Macrophages: The Role of CSF-1-Activated Phosphatidylinositol 3 Kinase and Src Family Kinase Motility Signaling
A Dwyer, E Greenland, F Pixley
Cancers 2017
Symmetrical retrograde actin flow in the actin fusion structure is involved in osteoclast fusion
J Takito, H Otsuka, S Inoue, T Kawashima, M Nakamura
Biology Open 2017
Expression of typical osteoclast markers by PBMCs after PEG-induced fusion as a model for studying osteoclast differentiation
LM Castillo, CA Guerrero, O Acosta
Journal Of Molecular Histology 2017
Targeted Agents in Preclinical and Early Clinical Development for the Treatment of Cancer Bone Metastases
T Hiraga
Expert Opinion on Investigational Drugs 2016
Proteomic approaches to study osteoclast biology
S Segeletz, B Hoflack
PROTEOMICS 2016
Role of miR-222-3p in c-Src-Mediated Regulation of Osteoclastogenesis
S Takigawa, A Chen, Q Wan, S Na, A Sudo, H Yokota, K Hamamura
International journal of molecular sciences 2016
Notch2 signaling promotes osteoclast resorption via activation of PYK2
WJ Jin, B Kim, JW Kim, HH Kim, H Ha, ZH Lee
Cellular Signalling 2016
Sanguiin H-6, a constituent of Rubus parvifolius L., inhibits receptor activator of nuclear factor-κB ligand-induced osteoclastogenesis and bone resorption in vitro and prevents tumor necrosis factor-α-induced osteoclast formation in vivo
E Sakai, Y Aoki, M Yoshimatsu, K Nishishita, M Iwatake, Y Fukuma, K Okamoto, T Tanaka, T Tsukuba
Phytomedicine 2016
Effects of Src-kinase inhibition in cancer-induced bone pain
MD Felice, D Lambert, I Holen, KJ Escott, D Andrew
Molecular Pain 2016
Src family kinase expression and subcellular localization in macrophages: implications for their role in CSF-1-induced macrophage migration
AR Dwyer, KA Mouchemore, JH Steer, AJ Sunderland, NG Sampaio, EL Greenland, DA Joyce, FJ Pixley
Journal of leukocyte biology 2016
Role of RANKL in the regulation of NFATc1 and c-Src mRNA expression in osteoclast-like cells
J Fu, YD Tao, J Chen, Y Zhang, J He
Molecular medicine reports 2016
Glycoprotein130 (Gp130)/interleukin-6 (IL-6) signalling in osteoclasts promotes bone formation in periosteal and trabecular bone
RW Johnson, NE McGregor, HJ Brennan, B Crimeen-Irwin, IJ Poulton, TJ Martin, NA Sims
Bone 2015
Src inhibitor reduces permeability without disturbing vascularization and prevents bone destruction in steroid-associated osteonecrotic lesions in rabbits
YX He, J Liu, B Guo, YX Wang, X Pan, D Li, T Tang, Y Chen, S Peng, Z Bian, Z Liang, BT Zhang, A Lu, G Zhang
Scientific Reports 2015
Blockage of Src by Specific siRNA as a Novel Therapeutic Strategy to Prevent Destructive Repair in Steroid-Associated Osteonecrosis in Rabbits: SRC BLOCKAGE PREVENTS DESTRUCTIVE REPAIR IN SAON
L Zheng, H Cao, S Chen, T Tang, W Fu, L Huang, DH Chow, Y Wang, JF Griffith, W He, H Zhou, D Zhao, G Zhang, X Wang, L Qin
Journal of Bone and Mineral Research 2015
Stauntonia hexaphylla (Lardizabalaceae) leaf methanol extract inhibits osteoclastogenesis and bone resorption activity via proteasome-mediated degradation of c-Fos protein and suppression of NFATc1 expression
YH Cheon, JM Baek, SH Park, SJ Ahn, MS Lee, J Oh, JY Kim
BMC complementary and alternative medicine 2015
Src enhances osteogenic differentiation through phosphorylation of Osterix
YH Choi, YH Han, SH Lee, H Cheong, KH Chun, CY Yeo, KY Lee
Molecular and Cellular Endocrinology 2015
Histochemical evidence of zoledronate inhibiting c-src expression and interfering with CD44/OPN-mediated osteoclast adhesion in the tibiae of mice
H Liu, J Cui, J Sun, J Du, W Feng, B Sun, J Li, X Han, B Liu, Yimin, K Oda, N Amizuka, M Li
Journal Of Molecular Histology 2015
Cancer-targeted therapies and radiopharmaceuticals
TD Rachner, F Jakob, LC Hofbauer
BoneKEy Reports 2015
Macrophages: Development and Tissue Specialization
C Varol, A Mildner, S Jung
Annual Review of Immunology 2015
Biology of the RANKL–RANK–OPG System in Immunity, Bone, and Beyond
MC Walsh, Y Choi
Frontiers in immunology 2014
SRC kinase inhibition with saracatinib limits the development of osteolytic bone disease in multiple myeloma
R Heusschen, J Muller, M Binsfeld, C Marty, E Plougonven, S Dubois, N Mahli, K Moermans, G Carmeliet, A Léonard, F Baron, Y Beguin, E Menu, M Cohen-Solal, J Caers
Oncotarget 2014
Regulation of Osteoclast Multinucleation by the Actin Cytoskeleton Signaling Network: ACTIN CYTOSKELETON IN OSTEOCLAST FUSION
J Takito, H Otsuka, N Yanagisawa, H Arai, M Shiga, M Inoue, N Nonaka, M Nakamura
Journal of Cellular Physiology 2014
The Roles of Small GTPases in Osteoclast Biology
MJ Oursler
Orthopedic & Muscular System 2014
Dissecting the role of bone marrow stromal cells on bone metastases
D Buenrostro, SI Park, JA Sterling
BioMed Research International 2014
Osteopetrosis in TAK1-deficient mice owing to defective NF-κB and NOTCH signaling
G Swarnkar, K Karuppaiah, G Mbalaviele, TH Chen, Y Abu-Amer
Proceedings of the National Academy of Sciences 2014
Advances in mechanisms of resistance to aromatase inhibitors
S Chumsri, A Schech, C Chakkabat, G Sabnis, A Brodie
Expert Review of Anticancer Therapy 2014
Potential anti-osteoporotic activity of low-molecular weight hyaluronan by attenuation of osteoclast cell differentiation and function in vitro
CW Lee, JY Seo, J Choi, J Lee, JW Park, JY Lee, KY Hwang, YS Park, YI Park
Biochemical and Biophysical Research Communications 2014
The Dectin 1 Agonist Curdlan Regulates Osteoclastogenesis by Inhibiting Nuclear Factor of Activated T cells Cytoplasmic 1 (NFATc1) through Syk Kinase
T Yamasaki, W Ariyoshi, T Okinaga, Y Adachi, R Hosokawa, S Mochizuki, K Sakurai, T Nishihara
The Journal of biological chemistry 2014
Reference Module in Biomedical Sciences
DL Sackett, RB Haynes
2014
Reactive oxygen species induce the association of SHP-1 with c-Src and the oxidation of both to enhance osteoclast survival
K Ke, OJ Sul, EK Choi, AM Safdar, ES Kim, HS Choi
American journal of physiology. Endocrinology and metabolism 2014
The RhoGAP Activity of Myosin IXB Is Critical for Osteoclast Podosome Patterning, Motility, and Resorptive Capacity
BK McMichael, KF Scherer, NC Franklin, BS Lee, PJ Marie
PloS one 2014
Mechanical Loading in Osteocytes Induces Formation of a Src/Pyk2/MBD2 Complex That Suppresses Anabolic Gene Expression
JM Hum, RN Day, JP Bidwell, Y Wang, FM Pavalko, ND Leipzig
PloS one 2014
The Role of Inflammatory Cytokines, the RANKL/OPG Axis, and the Immunoskeletal Interface in Physiological Bone Turnover and Osteoporosis
MN Weitzmann
Scientifica 2013
Postmenopausal osteoporosis: the role of immune system cells
MF Faienza, A Ventura, F Marzano, L Cavallo
Clinical & developmental immunology 2013
Loss of protein kinase C-δ protects against LPS-induced osteolysis owing to an intrinsic defect in osteoclastic bone resorption
EC Khor, T Abel, J Tickner, SM Chim, C Wang, T Cheng, B Ng, PY Ng, DA Teguh, J Kenny, X Yang, H Chen, KI Nakayama, K Nakayama, N Pavlos, MH Zheng, J Xu
PloS one 2013
Regulation of osteoclasts by membrane-derived lipid mediators
T Oikawa, Y Kuroda, K Matsuo
Cellular and Molecular Life Sciences 2013
Advances in osteoclast biology reveal potential new drug targets and new roles for osteoclasts
BF Boyce
Journal of Bone and Mineral Research 2013
Hck contributes to bone homeostasis by controlling the recruitment of osteoclast precursors
C Vérollet, A Gallois, R Dacquin, C Lastrucci, SN Pandruvada, N Ortega, R Poincloux, A Behar, C Cougoule, C Lowell, TA Saati, P Jurdic, I Maridonneau-Parini
The FASEB Journal 2013
Treatment options in castration-resistant prostate cancer: Current therapies and emerging docetaxel-based regimens☆
F Saad, K Miller
Urologic Oncology: Seminars and Original Investigations 2013
p130Cas, Crk-Associated Substrate, Plays Important Roles in Osteoclastic Bone Resorption: P130CAS REGULATES OSTEOCLASTIC BONE RESORPTION
Y Nagai, K Osawa, H Fukushima, Y Tamura, K Aoki, K Ohya, H Yasuda, H Hikiji, M Takahashi, Y Seta, S Seo, M Kurokawa, S Kato, H Honda, I Nakamura, K Maki, E Jimi
Journal of Bone and Mineral Research 2013
Loss of Protein Kinase C-δ Protects against LPS-Induced Osteolysis Owing to an Intrinsic Defect in Osteoclastic Bone Resorption
EC Khor, T Abel, J Tickner, SM Chim, C Wang, T Cheng, B Ng, PY Ng, DA Teguh, J Kenny, X Yang, H Chen, KI Nakayama, K Nakayama, N Pavlos, MH Zheng, J Xu, Y Komarova
PloS one 2013
Molecular Mechanism and Targeted Therapy Options of Triple-Negative (ER, PgR, HER-2/neu) Breast Cancer: Review
Kandula
World Journal of Oncology 2013
Biology and Regulation of Blood-Tissue Barriers
CY Cheng
2013
Protein Tyrosine Phosphatase Control of Metabolism
KK Bence
2013
Regulation of bone mass and osteoclast function depend on the F-actin modulator SWAP-70
AI Garbe, A Roscher, C Schüler, AH Lutter, M Glösmann, R Bernhardt, M Chopin, U Hempel, LC Hofbauer, S Rammelt, M Egerbacher, RG Erben, R Jessberger
Journal of Bone and Mineral Research 2012
PSTPIP2 deficiency in mice causes osteopenia and increased differentiation of multipotent myeloid precursors into osteoclasts
V Chitu, V Nacu, JF Charles, WM Henne, HT McMahon, S Nandi, H Ketchum, R Harris, MC Nakamura, ER Stanley
Blood 2012
ERK1 Regulates the Hematopoietic Stem Cell Niches
N Saulnier, S Guihard, X Holy, E Decembre, P Jurdic, D Clay, V Feuillet, G Pagès, J Pouysségur, F Porteu, M Gaudry
PloS one 2012
c-Src Links a RANK/ v 3 Integrin Complex to the Osteoclast Cytoskeleton
T Izawa, W Zou, JC Chappel, JW Ashley, X Feng, SL Teitelbaum
Molecular and cellular biology 2012
Serum calcium-decreasing factor, caldecrin, inhibits receptor activator of NF-κB ligand (RANKL)-mediated Ca2+ signaling and actin ring formation in mature osteoclasts via suppression of Src signaling pathway
M Tomomura, H Hasegawa, N Suda, H Sakagami, A Tomomura
The Journal of biological chemistry 2012
Fyn positively regulates the activation of DAP12 and FcRγ-mediated costimulatory signals by RANKL during osteoclastogenesis
HS Kim, DK Kim, AR Kim, SH Mun, SK Lee, JH Kim, YM Kim, WS Choi
Cellular Signalling 2012
Effects of Src kinase inhibition by saracatinib (AZD0530) on bone turnover in advanced malignancy in a Phase I study
RA Hannon, RD Finkelman, G Clack, RB Iacona, M Rimmer, F Gossiel, J Baselga, R Eastell
Bone 2012
Fluorescence-based experimental model to evaluate the concomitant effect of drugs on the tumour microenvironment and cancer cells
K Ramasamy, H Khatun, L Macpherson, MP Caley, J Sturge, GJ Mufti, SA Schey, Y Calle
British Journal of Haematology 2012
Src tyrosine kinase inhibitors in the treatment of lung cancer: rationale and clinical data
SI Rothschild, O Gautschi
Clinical Investigation 2012
Pediatric Bone
M Bastepe, H Jüppner, RV Thakker
Pediatric Bone 2012
The osteoclast, bone remodelling and treatment of metabolic bone disease: OSTEOCLASTS AND BONE REMODELLING
BF Boyce, E Rosenberg, AE de Papp, LT Duong
European Journal of Clinical Investigation 2012
Osteoclast migration, differentiation and function: novel therapeutic targets for rheumatic diseases
J Kikuta, M Ishii
Rheumatology 2012
ERK1 Regulates the Hematopoietic Stem Cell Niches
N Saulnier, S Guihard, X Holy, E Decembre, P Jurdic, D Clay, V Feuillet, G Pagès, J Pouysségur, F Porteu, M Gaudry, ES Abdelhay
PloS one 2012
Serum Calcium-decreasing Factor, Caldecrin, Inhibits Receptor Activator of NF-κB Ligand (RANKL)-mediated Ca 2+ Signaling and Actin Ring Formation in Mature Osteoclasts via Suppression of Src Signaling Pathway
M Tomomura, H Hasegawa, N Suda, H Sakagami, A Tomomura
The Journal of biological chemistry 2012
An osteoclastic protein-tyrosine phosphatase regulates the β 3 -integrin, syk, and shp1 signaling through respective src-dependent phosphorylation in osteoclasts
KH Lau, V Stiffel, M Amoui
American journal of physiology. Cell physiology 2012
Breast Cancer Metastasis and Drug Resistance
A Ahmad
2012
C-Src and c-Yes are two unlikely partners of spermatogenesis and their roles in blood-testis barrier dynamics.
Xiao X, Mruk DD, Cheng FL, Cheng CY
Advances in experimental medicine and biology 2012
3BP2 deficient mice are osteoporotic with impaired osteoblast and osteoclast functions
Noam Levaot, Paul D Simoncic, Ioannis D Dimitriou, Andrew Scotter, Jose La Rose, Adeline HM Ng, Thomas L Willett, Chiachien J Wang, Salima Janmohamed, Marc Grynpas, Ernst Reichenberger, Robert Rottapel
Journal of Clinical Investigation 2011
Osteoporosis: now and the future
TD Rachner, S Khosla, LC Hofbauer
Lancet 2011
RNA therapeutics targeting osteoclast-mediated excessive bone resorption
Y Wang, DW Grainger
Advanced Drug Delivery Reviews 2011
Advances in osteoclast biology: old findings and new insights from mouse models
JR Edwards, GR Mundy
Nature Reviews Rheumatology 2011
Loss of Tankyrase-Mediated Destruction of 3BP2 Is the Underlying Pathogenic Mechanism of Cherubism
N Levaot, O Voytyuk, I Dimitriou, F Sircoulomb, A Chandrakumar, M Deckert, PM Krzyzanowski, A Scotter, S Gu, S Janmohamed, F Cong, PD Simoncic, Y Ueki, J La Rose, R Rottapel
Cell 2011
Evidence that the kinase-truncated c-Src regulates NF-κB signaling by targeting NEMO
S Dai, W Abu-Amer, K Karuppaiah, Y Abu-Amer
Journal of Cellular Biochemistry 2011
Measurement by vertical scanning profilometry of resorption volume and lacunae depth caused by osteoclasts on dentine slices
F Pascaretti-Grizon, G Mabilleau, M Basle, D Chappard
Journal of Microscopy 2011
Src inhibitors in the treatment of metastatic bone disease: rationale and clinical data
B Boyce, L Xing
Clinical Investigation 2011
Regulation of osteoclast function
I Nakamura, N Takahashi, E Jimi, N Udagawa, T Suda
Modern Rheumatology 2011
Signaling networks regulating leukocyte podosome dynamics and function
A Dovas, D Cox
Cellular Signalling 2011
TAZ is required for the osteogenic and anti-adipogenic activities of kaempferol
MR Byun, H Jeong, SJ Bae, AR Kim, ES Hwang, JH Hong
Bone 2011
How are osteoclasts induced to resorb bone? : Chambers & Fuller
TJ Chambers, K Fuller
Annals of the New York Academy of Sciences 2011
Osteoclasts
FP Ross
Vitamin D 2011
Dasatinib Combined With Docetaxel For Castration-Resistant Prostate Cancer: Results From a Phase 1/2 Study
JC Araujo, P Mathew, AJ Armstrong, EL Braud, E Posadas, M Lonberg, GE Gallick, GC Trudel, P Paliwal, S Agrawal, CJ Logothetis
Cancer 2011
Mineral Trioxide Aggregate Inhibits Osteoclastic Bone Resorption
D Hashiguchi, H Fukushima, H Yasuda, W Masuda, M Tomikawa, K Morikawa, K Maki, E Jimi
Journal of dental research 2011
Signaling Pathways in Cancer Pathogenesis and Therapy
DA Frank
2011
Osteogenic Effects of a Potent Src-over-Abl-Selective Kinase Inhibitor in the Mouse
RJ Murrills, S Fukayama, F Boschelli, JJ Matteo, J Owens, JM Golas, D Patel, G Lane, YB Liu, L Carter, J Jussif, V Spaulding, YD Wang, DH Boschelli, JC McKew, XJ Li, S Lockhead, C Milligan, YP Kharode, V Diesl, Y Bai, M Follettie, FJ Bex, B Komm, PV Bodine
The Journal of pharmacology and experimental therapeutics 2011
Fyn promotes proliferation, differentiation, survival and function of osteoclast lineage cells
HJ Kim, JT Warren, SY Kim, JC Chappel, CJ DeSelm, FP Ross, W Zou, SL Teitelbaum
Journal of Cellular Biochemistry 2010
Osteoclasts Lacking Rac2 Have Defective Chemotaxis and Resorptive Activity
T Itokowa, M Zhu, N Troiano, J Bian, T Kawano, K Insogna
Calcified Tissue International 2010
Emerging Targets in Osteoporosis Disease Modification
JG Allen, C Fotsch, P Babij
Journal of Medicinal Chemistry 2010
Severe developmental bone phenotype in ClC-7 deficient mice
AV Neutzsky-Wulff, NA Sims, C Supanchart, U Kornak, D Felsenberg, IJ Poulton, TJ Martin, MA Karsdal, K Henriksen
Developmental Biology 2010
Regulation of Sealing Ring Formation by L-plastin and Cortactin in Osteoclasts*
T Ma, K Sadashivaiah, N Madayiputhiya, MA Chellaiah
The Journal of biological chemistry 2010
Shedding of RANKL by tumor-associated MT1-MMP activates Src-dependent prostate cancer cell migration
AL Sabbota, HR Kim, X Zhe, R Fridman, RD Bonfil, ML Cher
Cancer research 2010
c-Src-mediated phosphorylation of thyroid hormone receptor-interacting protein 6 (TRIP6) promotes osteoclast sealing zone formation
BK McMichael, SM Meyer, BS Lee
The Journal of biological chemistry 2010
3BP2 Adapter protein is required for receptor activator of NFkappaB ligand (RANKL)-induced osteoclast differentiation of RAW264.7 cells
A GuezGuez, V Prod'homme, X Mouska, A Baudot, C Blin-Wakkach, R Rottapel, M Deckert
The Journal of biological chemistry 2010
GPCR kinase 2 interacting protein 1 (GIT1) regulates osteoclast function and bone mass
P Menon, G Yin, EM Smolock, MJ Zuscik, C Yan, BC Berk
Journal of Cellular Physiology 2010
Src family kinase/abl inhibitor dasatinib suppresses proliferation and enhances differentiation of osteoblasts
YC Lee, CF Huang, M Murshed, K Chu, JC Araujo, X Ye, B deCrombrugghe, LY Yu-Lee, GE Gallick, SH Lin
Oncogene 2010
Pharmaceutical Sciences Encyclopedia
D Farkas, RI Shader, LL von Moltke, DJ Greenblatt
Pharmaceutical Sciences Encyclopedia 2010
Future directions of bone-targeted therapy for metastatic breast cancer
T Onishi, N Hayashi, RL Theriault, GN Hortobagyi, NT Ueno
Nature Reviews Clinical Oncology 2010
Bone metastases: Molecular mechanisms and novel therapeutic interventions
DJ Papachristou, EK Basdra, AG Papavassiliou
Medicinal Research Reviews 2010
Src is a major signaling component for CTGF induction by TGF-β1 in osteoblasts
X Zhang, JA Arnott, S Rehman, WG Delong, A Sanjay, FF Safadi, SN Popoff
Journal of Cellular Physiology 2010
Semisynthetic Src SH2 Domains Demonstrate Altered Phosphopeptide Specificity Induced by Incorporation of Unnatural Lysine Derivatives
S Virdee, D Macmillan, G Waksman
Chemistry & Biology 2010
Molecular Understanding of Osteoclast Differentiation and Physiology
NK Lee
Endocrinology and Metabolism 2010
SRC kinase inhibition: Targeting bone metastases and tumor growth in prostate and breast cancer
F Saad, A Lipton
Cancer Treatment Reviews 2010
Combining Src inhibitors and aromatase inhibitors: A novel strategy for overcoming endocrine resistance and bone loss
S Hiscox, P Barrett-Lee, AC Borley, RI Nicholson
European Journal of Cancer 2010
Expanding the role of Src and protein-tyrosine phosphatases balance in modulating osteoblast metabolism: Lessons from mice
WF Zambuzzi, R Milani, A Teti
Biochimie 2010
Effects of the Src kinase inhibitor saracatinib (AZD0530) on bone turnover in healthy men: A randomized, double-blind, placebo-controlled, multiple-ascending-dose phase I trial
RA Hannon, G Clack, M Rimmer, A Swaisland, JA Lockton, RD Finkelman, R Eastell
Journal of Bone and Mineral Research 2010
Effects of Altered Bone Remodeling and Retention of Cement Lines on Bone Quality in Osteopetrotic Aged c-Src-Deficient Mice
H Nakayama, K Takakuda, HN Matsumoto, A Miyata, O Baba, MJ Tabata, T Ushiki, T Oda, MD McKee, Y Takano
Calcified Tissue International 2010
Integrins, growth factors, and the osteoclast cytoskeleton
W Zou, SL Teitelbaum
Annals of the New York Academy of Sciences 2010
ADAM8 Enhances Osteoclast Precursor Fusion and Osteoclast Formation In Vitro and In Vivo
H Ishizuka, V García-Palacios, G Lu, MA Subler, H Zhang, CS Boykin, SJ Choi, L Zhao, K Patrene, DL Galson, HC Blair, TM Hadi, JJ Windle, N Kurihara, GD Roodman
Journal of Bone and Mineral Research 2010
Fundamentals of Osteoporosis
AM Parfitt
Fundamentals of Osteoporosis 2010
The tyrosine kinase inhibitor dasatinib dysregulates bone remodeling through inhibition of osteoclasts in vivo
K Vandyke, AL Dewar, P Diamond, S Fitter, CG Schultz, NA Sims, AC Zannettino
Journal of Bone and Mineral Research 2010
Histological and Histochemical Analyses of Cell-mediated Resorption of Anorganic Bovine Bone Matrix at the Site of Sinus Floor Augmentation in Humans
H Tamaki, H Nakayama, Y Takano
Journal of Oral Biosciences 2010
Dasatinib: a potent SRC inhibitor in clinical development for the treatment of solid tumors
J Araujo, C Logothetis
Cancer Treatment Reviews 2010
Src kinase inhibitors: an emerging therapeutic treatment option for prostate cancer
J Edwards
Expert Opinion on Investigational Drugs 2010
Regulation of Sealing Ring Formation by L-plastin and Cortactin in Osteoclasts
T Ma, K Sadashivaiah, MA Chellaiah
The Journal of biological chemistry 2010
3BP2 Adapter Protein Is Required for Receptor Activator of NFκB Ligand (RANKL)-induced Osteoclast Differentiation of RAW264.7 Cells
A GuezGuez, V Prod'homme, X Mouska, A Baudot, C Blin-Wakkach, R Rottapel, M Deckert
The Journal of biological chemistry 2010
Conformational Determinants of Phosphotyrosine Peptides Complexed with the Src SH2 Domain
J Nachman, G Gish, C Virag, T Pawson, R Pomès, E Pai, B Kobe
PloS one 2010
Bone Is Not Essential for Osteoclast Activation
K Fuller, JL Ross, KA Szewczyk, R Moss, TJ Chambers, M Klymkowsky
PloS one 2010
The Src family kinase, Lyn, suppresses osteoclastogenesis in vitro and in vivo
HJ Kim, K Zhang, L Zhang, FP Ross, SL Teitelbaum, R Faccio
Proceedings of the National Academy of Sciences 2009
Role of protein-tyrosine phosphatases in regulation of osteoclastic activity
MH Sheng, KH Lau
Cellular and molecular life sciences : CMLS 2009
Inhibition of the classical NF-κB pathway prevents osteoclast bone-resorbing activity
NS Soysa, N Alles, H Shimokawa, E Jimi, K Aoki, K Ohya
Journal of Bone and Mineral Metabolism 2009
Src as a therapeutic target in men with prostate cancer and bone metastases
F Saad
BJU International 2009
Targeting Src signaling in metastatic bone disease
J Araujo, C Logothetis
International Journal of Cancer 2009
Negative feedback control of osteoclast formation through ubiquitin-mediated down-regulation of NFATc1
JH Kim, K Kim, HM Jin, I Song, BU Youn, SH Lee, Y Choi, N Kim
The Journal of biological chemistry 2009
Cadmium osteotoxicity in experimental animals: mechanisms and relationship to human exposures
MH Bhattacharyya
Toxicology and Applied Pharmacology 2009
Activation of Src kinase by protein-tyrosine phosphatase-PEST in osteoclasts: Comparative analysis of the effects of bisphosphonate and protein-tyrosine phosphatase inhibitor on Src activation in vitro
MA Chellaiah, MD Schaller
Journal of Cellular Physiology 2009
Overexpression of cathepsin K accelerates the resorption cycle and osteoblast differentiation in vitro
J Morko, R Kiviranta, MT Mulari, KK Ivaska, HK Väänänen, E Vuorio, T Laitala-Leinonen
Bone 2009
Signaling Networks that Control the Lineage Commitment and Differentiation of Bone Cells
CS Soltanoff, S Yang, W Chen, YP Li
Critical reviews in eukaryotic gene expression 2009
Dasatinib inhibits both osteoclast activation and prostate cancer PC-3-cell-induced osteoclast formation
JC Araujo, A Poblenz, P Corn, NU Parikh, MW Starbuck, JT Thompson, F Lee, CJ Logothetis, BG Darnay
Cancer biology & therapy 2009
Dasatinib inhibits both osteoclast activation and prostate cancer PC-3 cell-induced osteoclast formation
JC Araujo, A Poblenz, PG Corn, NU Parikh, MW Starbuck, JT Thompson, F Lee, CJ Logothetis, BG Darnay
Cancer biology & therapy 2009
Inhibitory regulation of osteoclast bone resorption by signal regulatory protein α
EM van Beek, TJ de Vries, L Mulder, T Schoenmaker, KA Hoeben, T Matozaki, GE Langenbach, G Kraal, V Everts, TK van den Berg
The FASEB Journal 2009
The Novel Adaptor Protein Tks4 (SH3PXD2B) Is Required for Functional Podosome Formation
MD Buschman, PA Bromann, P Cejudo-Martin, F Wen, I Pass, SA Courtneidge, J Brugge
Molecular biology of the cell 2009
CD45 regulates retention, motility, and numbers of hematopoietic progenitors, and affects osteoclast remodeling of metaphyseal trabecules
S Shivtiel, O Kollet, K Lapid, A Schajnovitz, P Goichberg, A Kalinkovich, E Shezen, M Tesio, N Netzer, I Petit, A Sharir, T Lapidot
Journal of Experimental Medicine 2008
Osteoimmunology: interactions of the bone and immune system
J Lorenzo, M Horowitz, Y Choi
Endocrine reviews 2008
The Osteoclast: Friend or Foe?
DV Novack, SL Teitelbaum
Annual Review of Pathology: Mechanisms of Disease 2008
VEGF-C, a lymphatic growth factor, is a RANKL target gene in osteoclasts that enhances osteoclastic bone resorption through an autocrine mechanism
Q Zhang, R Guo, Y Lu, L Zhao, Q Zhou, EM Schwarz, J Huang, D Chen, ZG Jin, BF Boyce, L Xing
The Journal of biological chemistry 2008
Phospholipase Cγ2 Modulates Integrin Signaling in the Osteoclast by Affecting the Localization and Activation of Src Kinase
H Epple, V Cremasco, K Zhang, D Mao, GD Longmore, R Faccio
Molecular and cellular biology 2008
HCO3-/Cl- anion exchanger SLC4A2 is required for proper osteoclast differentiation and function
J Wu, LH Glimcher, AO Aliprantis
Proceedings of the National Academy of Sciences 2008
SAR of Carbon-Linked, 2-Substituted Purines: Synthesis and Characterization of AP23451 as a novel Bone-Targeted Inhibitor of Src Tyrosine Kinase With In Vivo Anti-Resorptive Activity
WC Shakespeare, Y Wang, R Bohacek, T Keenan, R Sundaramoorthi, C Metcalf, A Dilauro, S Roeloffzen, S Liu, J Saltmarsh, G Paramanathan, D Dalgarno, S Narula, S Pradeepan, MR van Schravendijk, J Keats, M Ram, S Liou, S Adams, S Wardwell, J Bogus, J Iuliucci, M Weigele, L Xing, B Boyce, TK Sawyer
Chemical Biology & Drug Design 2008
Structure, dynamics, and binding thermodynamics of the v-Src SH2 domain: Implications for drug design
JD Taylor, A Ababou, RR Fawaz, CJ Hobbs, MA Williams, JE Ladbury
Proteins: Structure, Function, and Bioinformatics 2008
The receptor protein tyrosine phosphatase PTP69D antagonizes Abl tyrosine kinase to guide axons in Drosophila
JK Song, E Giniger, CJ Desai
Mechanisms of Development 2008
Mechanisms of tooth eruption and orthodontic tooth movement
GE Wise, GJ King
Journal of dental research 2008
Therapeutic concentrations of dasatinib inhibit in vitro osteoclastogenesis
K Vandyke, AL Dewar, AN Farrugia, S Fitter, LB To, TP Hughes, AC Zannettino
Leukemia 2008
Differential subcellular membrane recruitment of Src may specify its downstream signalling
P Diesbach, T Medts, S Carpentier, L D'Auria, PV der Smissen, A Platek, M Mettlen, A Caplanusi, MF Hove, D Tyteca, PJ Courtoy
Experimental Cell Research 2008
Targeting Src in breast cancer
RS Finn
Annals of Oncology 2008
Osteopetrosis: from Animal Models to Human Conditions
B Perdu, W Hul, L Wesenbeeck
Clinical Reviews in Bone and Mineral Metabolism 2008
Principles of Bone Biology
CJ Rosen, T Niu
Principles of Bone Biology 2008
An Overview of Bone Cells and their Regulating Factors of Differentiation
AM Mohamed
The Malaysian Journal of Medical Sciences : MJMS 2008
VEGF-C, a Lymphatic Growth Factor, Is a RANKL Target Gene in Osteoclasts That Enhances Osteoclastic Bone Resorption through an Autocrine Mechanism
Q Zhang, R Guo, Y Lu, L Zhao, Q Zhou, EM Schwarz, J Huang, D Chen, ZG Jin, BF Boyce, L Xing
The Journal of biological chemistry 2008
Potential Molecular Mechanism for c-Src Kinase-mediated Regulation of Intestinal Cell Migration
S Mathew, SP George, Y Wang, MR Siddiqui, K Srinivasan, L Tan, S Khurana
The Journal of biological chemistry 2008
Parathyroid hormone mediates bone growth through the regulation of osteoblast proliferation and differentiation
GJ Pettway, JA Meganck, AJ Koh, ET Keller, SA Goldstein, LK McCauley
Bone 2007
Syk, c-Src, the alphavbeta3 integrin, and ITAM immunoreceptors, in concert, regulate osteoclastic bone resorption
W Zou, H Kitaura, J Reeve, F Long, VL Tybulewicz, SJ Shattil, MH Ginsberg, FP Ross, SL Teitelbaum
The Journal of Cell Biology 2007
Negative autoregulation of RANKL and c-Src signaling in osteoclasts
K Yogo, N Ishida-Kitagawa, T Takeya
Journal of Bone and Mineral Metabolism 2007
Liječenje Osteoporoze
P Šimić, Z Giljević, V Šimunić, S Vukičević, M Koršić
Archives of Industrial Hygiene and Toxicology 2007
Emerging pharmacologic therapies for osteoporosis
A Grey
Expert Opinion on Emerging Drugs 2007
Osteoimmunology
M Rauner, W Sipos, P Pietschmann
International Archives of Allergy and Immunology 2007
A transmembrane osteoclastic protein-tyrosine phosphatase regulates osteoclast activity in part by promoting osteoclast survival through c-Src-dependent activation of NFkappaB and JNK2
M Amoui, MH Sheng, ST Chen, DJ Baylink, KH Lau
Archives of Biochemistry and Biophysics 2007
Comprehensive Medicinal Chemistry II
E Littler, XX Zhou
Comprehensive Medicinal Chemistry II 2007
Phosphorylation of a Wiscott-Aldrich Syndrome Protein-associated Signal Complex Is Critical in Osteoclast Bone Resorption
MA Chellaiah, D Kuppuswamy, L Lasky, S Linder
The Journal of biological chemistry 2007
Diverse effects of c-src deficiency on molar tooth development and eruption in mice
A Miyata, O Baba, T Oda, I Ishikawa, Y Takano
Archives of Histology and Cytology 2007
The role of Src in prostate cancer
K Fizazi
Annals of Oncology 2007
Targeted Interference with Signal Transduction Events
B Groner
2007
Identification of a Novel Pyrazolo[3,4- d ]pyrimidine Able To Inhibit Cell Proliferation of a Human Osteogenic Sarcoma in Vitro and in a Xenograft Model in Mice
F Manetti, A Santucci, GA Locatelli, G Maga, A Spreafico, T Serchi, M Orlandini, G Bernardini, NP Caradonna, A Spallarossa, C Brullo, S Schenone, O Bruno, A Ranise, F Bondavalli, O Hoffmann, M Bologna, A Angelucci, M Botta
Journal of Medicinal Chemistry 2007
Future Anti-Catabolic Therapeutic Targets in Bone Disease
BF Boyce
Annals of the New York Academy of Sciences 2006
An osteoclastic protein-tyrosine phosphatase is a potential positive regulator of the c-Src protein-tyrosine kinase activity: A mediator of osteoclast activity
KH Lau, LW Wu, MH Sheng, M Amoui, SM Suhr, DJ Baylink
Journal of Cellular Biochemistry 2006
Regulation of osteoclast function and bone mass by RAGE
Z Zhou, D Immel, CX Xi, A Bierhaus, X Feng, L Mei, P Nawroth, DM Stern, WC Xiong
Journal of Experimental Medicine 2006
Molecular regulation of osteoclast activity
A Bruzzaniti, R Baron
Reviews in Endocrine and Metabolic Disorders 2006
Critical role of cortactin in actin ring formation and osteoclastic bone resorption
T Matsubara, A Myoui, F Ikeda, K Hata, H Yoshikawa, R Nishimura, T Yoneda
Journal of Bone and Mineral Metabolism 2006
Herbal formulation, Yukmi-jihang-tang-Jahage, regulates bone resorption by inhibition of phosphorylation mediated by tyrosine kinase Src and cyclooxygenase expression
UH Jin, DI Kim, TK Lee, DN Lee, JK Kim, IS Lee, CH Kim
Journal of Ethnopharmacology 2006
Regulation of Osteoclast Differentiation (Identification of osteoclast and macrophage fusion protein; DC-STAMP)
T Miyamoto
Journal of Korean Endocrine Society 2006
c-Src control of chloride channel support for osteoclast HCl transport and bone resorption
JC Edwards, C Cohen, W Xu, PH Schlesinger
The Journal of biological chemistry 2006
Caspase-2 deficiency enhances aging-related traits in mice
Y Zhang, SS Padalecki, AR Chaudhuri, ED Waal, BA Goins, B Grubbs, Y Ikeno, A Richardson, GR Mundy, B Herman
Mechanisms of Ageing and Development 2006
Osteoclasts play a part in pain due to the inflammation adjacent to bone
M Nagae, T Hiraga, H Wakabayashi, L Wang, K Iwata, T Yoneda
Bone 2006
Involvement of the SH3 domain in Ca2+-mediated regulation of Src family kinases
AN Monteiro
Biochimie 2006
Preparation of Low Density Lipoprotein from Large Apheresis Cartridges for Induction of Cell Death in Saos2 Osteoblasts
BY Klein, Z Kerem, N Rojansky
Therapeutic Apheresis and Dialysis 2006
LDL induces Saos2 osteoblasts death via Akt pathways responsive to a neutral sphingomyelinase inhibitor
BY Klein, Z Kerem, N Rojansky
Journal of Cellular Biochemistry 2006
Src Triggers Circular Ruffling and Macropinocytosis at the Apical Surface of Polarized MDCK Cells
M Mettlen, A Platek, PV der Smissen, S Carpentier, M Amyere, L Lanzetti, P Diesbach, D Tyteca, PJ Courtoy
Traffic 2006
Matricellular proteins: Extracellular modulators of bone development, remodeling, and regeneration
AI Alford, KD Hankenson
Bone 2006
Structural features of incremental line-like striations in mandibular condylar cartilage of c-src-deficient mice
S Shibata, T Oda, T Abe, Y Yamashita, Y Takano
Archives of Oral Biology 2006
Dynamics of Bone and Cartilage Metabolism
JE Mulder, CA Kulak, E Shane
Dynamics of Bone and Cartilage Metabolism 2006
Review of the Effects of Anti-Angiogenic Compounds on the Epiphyseal Growth Plate
AP Hall, FR Westwood, PF Wadsworth
Toxicologic pathology 2006
Osteoclasts and Integrins
SL Teitelbaum
Annals of the New York Academy of Sciences 2006
Src Homology 2 (SH2)-Containing 5′-Inositol Phosphatase Localizes to Podosomes, and the SH2 Domain Is Implicated in the Attenuation of Bone Resorption in Osteoclasts
K Yogo, M Mizutamari, K Mishima, H Takenouchi, N Ishida-Kitagawa, T Sasaki, T Takeya
Endocrinology 2006
Activation of NFAT Signal In Vivo Leads to Osteopenia Associated with Increased Osteoclastogenesis and Bone-Resorbing Activity
F Ikeda, R Nishimura, T Matsubara, K Hata, SV Reddy, T Yoneda
Journal of immunology (Baltimore, Md. : 1950) 2006
Paget disease of bone
GD Roodman, JJ Windle
Journal of Clinical Investigation 2005
Osteoclasts; culprits in inflammatory osteolysis
SL Teitelbaum
Arthritis Research & Therapy 2005
Roles for NF-κB and c-Fos in osteoclasts
BF Boyce, T Yamashita, Z Yao, Q Zhang, F Li, L Xing
Journal of Bone and Mineral Metabolism 2005
DC-STAMP is essential for cell–cell fusion in osteoclasts and foreign body giant cells
M Yagi, T Miyamoto, Y Sawatani, K Iwamoto, N Hosogane, N Fujita, K Morita, K Ninomiya, T Suzuki, K Miyamoto, Y Oike, M Takeya, Y Toyama, T Suda
Journal of Experimental Medicine 2005
Recent advances in the discovery of Src kinase inhibitors
K Parang, G Sun
Expert Opinion on Therapeutic Patents 2005
alphavbeta3 and macrophage colony-stimulating factor: partners in osteoclast biology
FP Ross, SL Teitelbaum
Immunological Reviews 2005
Emerging and potential therapies for osteoporosis
A Grey, IR Reid
Expert Opinion on Investigational Drugs 2005
Regulation of apoptosis in osteoclasts and osteoblastic cells
L Xing, BF Boyce
Biochemical and Biophysical Research Communications 2005
The role(s) of Src kinase and Cbl proteins in the regulation of osteoclast differentiation and function
WC Horne, A Sanjay, A Bruzzaniti, R Baron
Immunological Reviews 2005
CSF-1 Induces fos Gene Transcription and Activates the Transcription Factor Elk-1 in Mature Osteoclasts
GQ Yao, T Itokawa, I Paliwal, K Insogna
Calcified Tissue International 2005
The role of macrophages in osteolysis of total joint replacement
E Ingham, J Fisher
Biomaterials 2005
SC-19220, Antagonist of Prostaglandin E2 Receptor EP1, Inhibits Osteoclastogenesis by RANKL
T Tsujisawa, H Inoue, T Nishihara
Journal of Bone and Mineral Research 2005
The glutamatergic system outside the CNS and in cancer biology
N Kalariti, N Pissimissis, M Koutsilieris
Expert Opinion on Investigational Drugs 2005
A RANKL-Inducible Gene Znf216 in Osteoclast Differentiation
A Hishiya, K Ikeda, K Watanabe
Journal of Receptors and Signal Transduction 2005
Src64 is involved in fusome development and karyosome formation during Drosophila oogenesis
I Djagaeva, S Doronkin, SK Beckendorf
Developmental Biology 2005
Intracellular signal transduction pathways: good therapeutic targets for joint destruction in rheumatoid arthritis
S Tanaka
Modern Rheumatology 2005
c-Yes response to growth factor activation: Mini Review
DA Clump, DA Clump, IH Qazi, DA Clump, IH Qazi, M Sudol, DC Flynn
Growth Factors 2005
Physical and Functional Association of c-Src and Adhesion and Degranulation Promoting Adaptor Protein (ADAP) in Osteoclastogenesis in Vitro
S Koga, K Yogo, K Yoshikawa, H Samori, M Goto, T Uchida, N Ishida, T Takeya
The Journal of biological chemistry 2005
Bone Resorption
F Bronner, MC Farach-Carson, J Rubin
2005
Absence of Fyn and Src Causes a Reeler-Like Phenotype
G Kuo
The Journal of neuroscience : the official journal of the Society for Neuroscience 2005
Proteomics and Protein-Protein Interactions
G Waksman
2005
Bacterial Protein Toxins: Role in the Interference with Cell Growth Regulation
AJ Lax
2005
Systemic tumor necrosis factor alpha mediates an increase in peripheral CD11bhigh osteoclast precursors in tumor necrosis factor alpha-transgenic mice
P Li, EM Schwarz, RJ O'Keefe, L Ma, RJ Looney, CT Ritchlin, BF Boyce, L Xing
Arthritis & Rheumatism 2004
Genetically Modified Animal Models as Tools for Studying Bone and Mineral Metabolism
RA Davey, HE MacLean, JF McManus, DM Findlay, JD Zajac
Journal of Bone and Mineral Research 2004
Localization of Tec29 to ring canals is mediated by Src64 and PtdIns(3,4,5)P3-dependent mechanisms
N Lu, DJ Guarnieri, MA Simon
The EMBO Journal 2004
Tyrosine phosphorylation controls Runx2-mediated subnuclear targeting of YAP to repress transcription
SK Zaidi, AJ Sullivan, R Medina, Y Ito, AJ van Wijnen, JL Stein, JB Lian, GS Stein
The EMBO Journal 2004
Tyrosine phosphatase epsilon is a positive regulator of osteoclast function in vitro and in vivo
R Chiusaroli, H Knobler, C Luxenburg, A Sanjay, S Granot-Attas, Z Tiran, T Miyazaki, A Harmelin, R Baron, A Elson
Molecular biology of the cell 2004
ATP-phosphopeptide conjugates as inhibitors of Src tyrosine kinases
NH Nam, S Lee, G Ye, G Sun, K Parang
Bioorganic & Medicinal Chemistry 2004
Induction of mouse c-src in RAW264 cells is dependent on AP-1 and NF-κB and important for progression to multinucleated cell formation
N Kumagai, K Ohno, R Tameshige, M Hoshijima, K Yogo, N Ishida, T Takeya
Biochemical and Biophysical Research Communications 2004
Cancer metastasis therapeutic targets and drug discovery: emerging small-molecule protein kinase inhibitors
TK Sawyer
Expert Opinion on Investigational Drugs 2004
Reduction of c-Src activity by substituted 5,7-diphenyl-pyrrolo[2,3-d]-pyrimidines induces osteoclast apoptosis in vivo and in vitro. Involvement of ERK1/2 pathway
I Recchia, N Rucci, A Funari, S Migliaccio, A Taranta, M Longo, M Kneissel, M Šuša, D Fabbro, A Teti
Bone 2004
Physiological role of mGSTA4-4, a glutathione S-transferase metabolizing 4-hydroxynonenal: generation and analysis of mGsta4 null mouse
MR Engle, SP Singh, PJ Czernik, D Gaddy, DC Montague, JD Ceci, Y Yang, S Awasthi, YC Awasthi, P Zimniak
Toxicology and Applied Pharmacology 2004
SH3P2 in complex with Cbl and Src
I Szymkiewicz, O Destaing, P Jurdic, I Dikic
FEBS Letters 2004
Highlights from: The 2nd Annual Future of Supportive Therapy in Oncology; St. Kitts, West Indies
N Price, GK Reddy, VK Jain
Supportive Cancer Therapy 2004
Bone Tissue Engineering
H Donahue, E Vogler, C Siedlecki
Bone Tissue Engineering 2004
Osteoclastic bone resorption through receptor tyrosine kinase and extracellular signal-regulated kinase signaling in mature osteoclasts
H Kawaguchi, M Katagiri, D Chikazu
Modern Rheumatology 2004
N ew M olecules in the T umor N ecrosis F actor L igand and R eceptor S uperfamilies with I mportance for P hysiological and P athological B one R esorption
UH Lerner
Critical Reviews in Oral Biology & Medicine 2004
Hematological defects in the oc/oc mouse, a model of infantile malignant osteopetrosis
C Blin-Wakkach, A Wakkach, PM Sexton, N Rochet, GF Carle
Leukemia 2004
Bone remodeling: new aspects of a key process that controls skeletal maintenance and repair
P Pogoda, M Priemel, JM Rueger, M Amling
Osteoporosis International 2004
The Skeleton
EJ Massaro, JM Rogers
2004
Collagenase cleavage of type I collagen is essential for both basal and parathyroid hormone (PTH)/PTH-related peptide receptor-induced osteoclast activation and has differential effects on discrete bone compartments
R Chiusaroli, A Maier, MC Knight, M Byrne, LM Calvi, R Baron, SM Krane, E Schipani
Endocrinology 2003
Genetic regulation of osteoclast development and function
SL Teitelbaum, FP Ross
Nature Reviews Genetics 2003
Regulation of the formation of osteoclastic actin rings by proline-rich tyrosine kinase 2 interacting with gelsolin
Q Wang, Y Xie, QS Du, XJ Wu, X Feng, L Mei, JM McDonald, WC Xiong
The Journal of Cell Biology 2003
Mesenchymal progenitor self-renewal deficiency leads to age-dependent osteoporosis in Sca-1/Ly-6A null mice
M Bonyadi, SD Waldman, D Liu, JE Aubin, MD Grynpas, WL Stanford
Proceedings of the National Academy of Sciences 2003
Participation of protein kinase c β in osteoclast differentiation and function
SW Lee, HB Kwak, WJ Chung, H Cheong, HH Kim, ZH Lee
Bone 2003
Association of natural tooth loss with genetic variation at the SRC locus among elderly women in Japan
H Hirano, Y Ezura, H Yoshida, T Suzuki, T Hosoi, M Emi
Geriatrics and Gerontology International 2003
Regulation of bone remodeling and emerging breakthrough drugs for osteoporosis and osteolytic bone metastases
BF Boyce, L Xing, W Shakespeare, Y Wang, D Dalgarno, J Iuliucci, T Sawyer
Kidney International 2003
Biology of the TRANCE axis
MC Walsh, Y Choi
Cytokine & Growth Factor Reviews 2003
Bone-Targeted pyrido[2,3-d]pyrimidin-7-ones: potent inhibitors of Src tyrosine kinase as novel antiresorptive agents
CB Vu, GP Luke, N Kawahata, WC Shakespeare, Y Wang, R Sundaramoorthi, CA Metcalf, TP Keenan, S Pradeepan, E Corpuz, T Merry, RS Bohacek, DC Dalgarno, SS Narula, MR van Schravendijk, MK Ram, S Adams, S Liou, JA Keats, SM Violette, W Guan, M Weigele, TK Sawyer
Bioorganic & Medicinal Chemistry Letters 2003
Expression of Either NF-κB p50 or p52 in Osteoclast Precursors Is Required for IL-1-Induced Bone Resorption
L Xing, L Carlson, B Story, Z Tai, P Keng, U Siebenlist, BF Boyce
Journal of Bone and Mineral Research 2003
RANK-Fc: A therapeutic antagonist for RANK-L in myeloma
EM Sordillo, RN Pearse
Cancer 2003
Regulation of cytochrome c oxidase activity by c-Src in osteoclasts
T Miyazaki, L Neff, S Tanaka, WC Horne, R Baron
The Journal of Cell Biology 2003
Membrane Rafts Play a Crucial Role in Receptor Activator of Nuclear Factor κB Signaling and Osteoclast Function
H Ha, HB Kwak, SK Lee, DS Na, CE Rudd, ZH Lee, HH Kim
The Journal of biological chemistry 2003
Bisphosphonates and metastatic breast carcinoma
A Lipton
Cancer 2003
Cell death in cultured human Saos2 osteoblasts exposed to low-density lipoprotein
BY Klein, N Rojansky, A Ben-Yehuda, I Abou-Atta, S Abedat, G Friedman
Journal of Cellular Biochemistry 2003
The SH4-Unique-SH3-SH2 domains dictate specificity in signaling that differentiate c-Yes from c-Src
JM Summy, Y Qian, BH Jiang, A Guappone-Koay, A Gatesman, X Shi, DC Flynn
Journal of cell science 2003
DIRECTIONS OFDRUGDISCOVERY INOSTEOPOROSIS
GR Mundy
Annual Review of Medicine 2002
Emerging techniques for the discovery and validation of therapeutic targets for skeletal diseases
CH Cho, ME Nuttall
Expert Opinion on Therapeutic Targets 2002
Down-Regulation of Osteoclast Differentiation by Daidzein via Caspase 3
CM Rassi, M Lieberherr, G Chaumaz, A Pointillart, G Cournot
Journal of Bone and Mineral Research 2002
Inhibitory Effect of Carthamus tinctorius L. Seed Extracts on Bone Resorption Mediated by Tyrosine Kinase, COX-2 (cyclooxygenase) and PG (prostaglandin) E 2
TH Yuk, JH Kang, SR Lee, SW Yuk, KG Lee, BY Song, CH Kim, DW Kim, DI Kim, TK Lee, CH Lee
The American journal of Chinese medicine 2002
Drosophila Kelch regulates actin organization via Src64-dependent tyrosine phosphorylation
RJ Kelso, AM Hudson, L Cooley
The Journal of Cell Biology 2002
c-Src-dependent Transcriptional Activation of TFII-I
V Cheriyath, ZP Desgranges, AL Roy
The Journal of biological chemistry 2002
A RANK/TRAF6-dependent Signal Transduction Pathway Is Essential for Osteoclast Cytoskeletal Organization and Resorptive Function
AP Armstrong, ME Tometsko, M Glaccum, CL Sutherland, D Cosman, WC Dougall
The Journal of biological chemistry 2002
IL-1 Regulates Cytoskeletal Organization in Osteoclasts Via TNF Receptor-Associated Factor 6/c-Src Complex
I Nakamura, Y Kadono, H Takayanagi, E Jimi, T Miyazaki, H Oda, K Nakamura, S Tanaka, GA Rodan, LT Duong
Journal of immunology (Baltimore, Md. : 1950) 2002
Receptor Activator of NF-κB Ligand (RANKL) Activates TAK1 Mitogen-Activated Protein Kinase Kinase Kinase through a Signaling Complex Containing RANK, TAB2, and TRAF6
J Mizukami, G Takaesu, H Akatsuka, H Sakurai, J Ninomiya-Tsuji, K Matsumoto, N Sakurai
Molecular and cellular biology 2002
Principles Governing the Binding of a Class of Non-Peptidic Inhibitors to the SH2 Domain of src Studied by X-ray Analysis
G Lange, D Lesuisse, P Deprez, B Schoot, P Loenze, D Bénard, JP Marquette, P Broto, E Sarubbi, E Mandine
Journal of Medicinal Chemistry 2002
SAR and X-ray. A New Approach Combining Fragment-Based Screening and Rational Drug Design: Application to the Discovery of Nanomolar Inhibitors of Src SH2
D Lesuisse, G Lange, P Deprez, D Bénard, B Schoot, G Delettre, JP Marquette, P Broto, V Jean-Baptiste, P Bichet, E Sarubbi, E Mandine
Journal of Medicinal Chemistry 2002
Tissue Inhibitor of Metalloproteinases 1 and 2 Directly Stimulate the Bone-Resorbing Activity of Isolated Mature Osteoclasts
T Sobue, Y Hakeda, Y Kobayashi, H Hayakawa, K Yamashita, T Aoki, M Kumegawa, T Noguchi, T Hayakawa
Journal of Bone and Mineral Research 2001
Bone-targeted Src SH2 inhibitors block Src cellular activity and osteoclast-mediated resorption
SM Violette, W Guan, C Bartlett, JA Smith, C Bardelay, E Antoine, RJ Rickles, E Mandine, MR Schravendijk, SE Adams, BA Lynch, WC Shakespeare, M Yang, VA Jacobsen, CS Takeuchi, KJ Macek, RS Bohacek, DC Dalgarno, M Weigele, D Lesuisse, TK Sawyer, R Baron
Bone 2001
Src inhibitors: genomics to therapeutics
T Sawyer, B Boyce, D Dalgarno, J Iuliucci
Expert Opinion on Investigational Drugs 2001
Antisense Oligodeoxynucleotide Evidence That a Unique Osteoclastic Protein-Tyrosine Phosphatase Is Essential for Osteoclastic Resorption
SM Suhr, S Pamula, DJ Baylink, KH Lau
Journal of Bone and Mineral Research 2001
Genetic evidence for a role for Src family kinases in TNF family receptor signaling and cell survival
L Xing, AM Venegas, A Chen, L Garrett-Beal, BF Boyce, HE Varmus, PL Schwartzberg
Genes & development 2001
Convergence of alpha(v)beta(3) integrin- and macrophage colony stimulating factor-mediated signals on phospholipase Cgamma in prefusion osteoclasts
I Nakamura, L Lipfert, GA Rodan, LT Duong
The Journal of Cell Biology 2001
The Src Signaling Pathway Regulates Osteoclast Lysosomal Enzyme Secretion and Is Rapidly Modulated by Estrogen
D Pascoe, MJ Oursler
Journal of Bone and Mineral Research 2001
Genistein, a Soybean Isoflavone, Inhibits Inward Rectifier K+ Channels in Rat Osteoclasts
F Okamoto, K Okabe, H Kajiya
The Japanese Journal of Physiology 2001
Convergence of  v 3Integrin-And Macrophage Colony Stimulating Factor-Mediated Signals on Phospholipase C  in Prefusion Osteoclasts
I Nakamura, L Lipfert, GA Rodan, LT Duong
The Journal of Cell Biology 2001
7-Alkyl- and 7-Cycloalkyl-5-aryl-pyrrolo[2,3-d]pyrimidines—potent inhibitors of the tyrosine kinase c-Src
L Widler, J Green, M Missbach, M Šuša, E Altmann
Bioorganic & Medicinal Chemistry Letters 2001
7-Pyrrolidinyl- and 7-piperidinyl-5-aryl-pyrrolo[2,3-d]pyrimidines—potent inhibitors of the tyrosine kinase c-Src
E Altmann, M Missbach, J Green, M Šuša, HA Wagenknecht, L Widler
Bioorganic & Medicinal Chemistry Letters 2001
The mouse osteopetrotic grey-lethal mutation induces a defect in osteoclast maturation/function
V Rajapurohitam, N Chalhoub, N Benachenhou, L Neff, R Baron, J Vacher
Bone 2001
Brain and Bone: Central Regulation of Bone Mass: A New Paradigm in Skeletal Biology
M Haberland, AF Schilling, JM Rueger, M Amling
The Journal of Bone and Joint Surgery. American volume. 2001
Osteoclast-stimulating Factor Interacts with the Spinal Muscular Atrophy Gene Product to Stimulate Osteoclast Formation
N Kurihara, C Menaa, H Maeda, DJ Haile, SV Reddy
The Journal of biological chemistry 2001
Phosphatidylinositol 3,4,5-Trisphosphate Directs Association of Src Homology 2-containing Signaling Proteins with Gelsolin
MA Chellaiah, RS Biswas, D Yuen, UM Alvarez, KA Hruska
The Journal of biological chemistry 2001
UCS15A, a non-kinase inhibitor of Src signal transduction
SV Sharma, C Oneyama, Y Yamashita, H Nakano, K Sugawara, M Hamada, N Kosaka, T Tamaoki
Oncogene 2001
Noninvasive Assessment of Trabecular Bone Architecture and the Competence of Bone
S Majumdar, BK Bay
2001
Abnormal localisation and hyperclustering of (alpha)(V)(beta)(3) integrins and associated proteins in Src-deficient or tyrphostin A9-treated osteoclasts
PT Lakkakorpi, I Nakamura, M Young, L Lipfert, GA Rodan, LT Duong
Journal of cell science 2001
Synthesis and Src Kinase Inhibitory Activity of a Series of 4-Phenylamino-3-quinolinecarbonitriles
DH Boschelli, YD Wang, F Ye, B Wu, N Zhang, M Dutia, DW Powell, A Wissner, K Arndt, JM Weber, F Boschelli
Journal of Medicinal Chemistry 2001
In Vitro and In Vivo Suppression of Osteoclast Function by Adenovirus Vector-Induced csk Gene
T Miyazaki, H Takayanagi, M Isshiki, T Takahashi, M Okada, Y Fukui, H Oda, K Nakamura, H Hirai, T Kurokawa, S Tanaka
Journal of Bone and Mineral Research 2000
Superoxide generation and tyrosine kinase
S Yang, M Hardaway, G Sun, WL Ries, LL Key
Biochemistry and Cell Biology 2000
A Src SH2 selective binding compound inhibits osteoclast-mediated resorption
SM Violette, WC Shakespeare, C Bartlett, W Guan, JA Smith, RJ Rickles, RS Bohacek, DA Holt, R Baron, TK Sawyer
Chemistry & Biology 2000
Protein tyrosine kinase inhibitors increase cytosolic calcium and inhibit actin organization as resorbing activity in rat osteoclasts
H Kajiya, K Okabe, F Okamoto, T Tsuzuki, H Soeda
Journal of Cellular Physiology 2000
Emerging therapies for osteoporosis
M Gowen, JG Emery, S Kumar
Expert Opinion on Emerging Drugs 2000
Metabolic bone disease: Lessons from knockout mice
AC Karaplis
Drug Development Research 2000
Integrins and signaling in osteoclast function
LT Duong, P Lakkakorpi, I Nakamura, GA Rodan
Matrix Biology 2000
Decreased c-Src expression enhances osteoblast differentiation and bone formation
M Marzia, NA Sims, S Voit, S Migliaccio, A Taranta, S Bernardini, T Faraggiana, T Yoneda, GR Mundy, BF Boyce, R Baron, A Teti
The Journal of Cell Biology 2000
Structure-based design of an osteoclast-selective, nonpeptide src homology 2 inhibitor with in vivo antiresorptive activity
W Shakespeare, M Yang, R Bohacek, F Cerasoli, K Stebbins, R Sundaramoorthi, M Azimioara, C Vu, S Pradeepan, CM 3rd, C Haraldson, T Merry, D Dalgarno, S Narula, M Hatada, X Lu, MR van Schravendijk, S Adams, S Violette, J Smith, W Guan, C Bartlett, J Herson, J Iuliucci, M Weigele, T Sawyer
Proceedings of the National Academy of Sciences 2000
Gelsolin deficiency blocks podosome assembly and produces increased bone mass and strength
M Chellaiah, N Kizer, M Silva, U Alvarez, D Kwiatkowski, KA Hruska
The Journal of Cell Biology 2000
A CD36-Binding Peptide from Thrombospondin-1 Can Stimulate Resorption by Osteoclasts in Vitro
JA Carron, SC Wagstaff, JA Gallagher, WB Bowler
Biochemical and Biophysical Research Communications 2000
Specific Antagonists of NMDA Receptors Prevent Osteoclast Sealing Zone Formation Required for Bone Resorption
C Itzstein, L Espinosa, PD Delmas, C Chenu
Biochemical and Biophysical Research Communications 2000
Regulation of Collagenolytic Protease Secretion through c-Src in Osteoclasts
N Furuyama, Y Fujisawa
Biochemical and Biophysical Research Communications 2000
Osteoclast formation and resorption
UH Lerner
Matrix Biology 2000
Estrogen stimulates protein tyrosine phosphorylation and Src kinase activity in avian osteoclasts
KD Brubaker, CV Gay
Journal of Cellular Biochemistry 2000
Decreased C-Src Expression Enhances Osteoblast Differentiation and Bone Formation
M Marzia, NA Sims, S Voit, S Migliaccio, A Taranta, S Bernardini, T Faraggiana, T Yoneda, GR Mundy, BF Boyce, R Baron, A Teti
The Journal of Cell Biology 2000
Computational binding studies of human pp60c-src SH2 domain with a series of nonpeptide, phosphophenyl-containing ligands
DJ Price, WL Jorgensen
Bioorganic & Medicinal Chemistry Letters 2000
Mouse Genetics Have Uncovered New Paradigms in Bone Biology
T Günther, T Schinke
Trends in Endocrinology & Metabolism 2000
A neuro (endo)crine regulation of bone remodeling
M Amling, S Takeda, G Karsenty
BioEssays 2000
Study of the Nonresorptive Phenotype of Osteoclast-like Cells from Patients with Malignant Osteopetrosis: A New Approach to Investigating Pathogenesis
AM Flanagan, U Sarma, CG Steward, A Vellodi, MA Horton
Journal of Bone and Mineral Research 2000
A Novel Synthetic Triazolotriazepine Derivative JTT-606 Inhibits Bone Resorption by Down-Regulation of Action and Production of Bone Resorptive Factors
D Chikazu, M Shindo, T Iwasaka, M Katagiri, N Manabe, T Takato, K Nakamura, H Kawaguchi
Journal of Bone and Mineral Research 2000
Induction of c-Src in Human Blood Monocytes by Anti-CD98/FRP-1 mAb in an Sp1-Dependent Fashion
N Miyamoto, Y Higuchi, M Tsurudome, M Ito, M Nishio, M Kawano, A Sudo, K Kato, A Uchida, Y Ito
Cellular Immunology 2000
Progressive increase in bone mass and development of odontomas in aging osteopetrotic c-src-deficient mice
M Amling, L Neff, M Priemel, AF Schilling, JM Rueger, R Baron
Bone 2000
Breakthrough in bone: the molecular mechanism of osteoclast/osteoblast coupling revealed
EM Schwarz, RJ O'Keefe
Current Opinion in Orthopedics 2000
Structure-based design of an osteoclast-selective, nonpeptide Src homology 2 inhibitor with in vivo antiresorptive activity
W Shakespeare, M Yang, R Bohacek, F Cerasoli, K Stebbins, R Sundaramoorthi, M Azimioara, C Vu, S Pradeepan, C Metcalf, C Haraldson, T Merry, D Dalgarno, S Narula, M Hatada, X Lu, MR van Schravendijk, S Adams, S Violette, J Smith, W Guan, C Bartlett, J Herson, J Iuliucci, M Weigele, T Sawyer
Proceedings of the National Academy of Sciences 2000
Stimulatory effect of curcumin on osteoclast apoptosis
K Ozaki, Y Kawata, S Amano, S Hanazawa
Biochemical Pharmacology 2000
Active Recombinant Human Tyrosine Kinase c-Yes: Expression in Baculovirus System, Purification, Comparison to c-Src, and Inhibition by a c-Src Inhibitor
M Šuša, NH Luong-Nguyen, J Crespo, R Maier, M Missbach, G McMaster
Protein Expression and Purification 2000
Development of inhibitors for protein tyrosine kinases
FA Al-Obeidi, KS Lam
Oncogene 2000
Chimeric constructs containing the SH4/Unique domains of cYes can restrict the ability of Src527F to upregulate heme oxygenase-1 expression efficiently
JG Hoey, J Summy, DC Flynn
Cellular Signalling 2000
Rho-A Is Critical for Osteoclast Podosome Organization, Motility, and Bone Resorption
MA Chellaiah, N Soga, S Swanson, S McAllister, U Alvarez, D Wang, SF Dowdy, KA Hruska
The Journal of biological chemistry 2000
Evidence for a Functional Association between Phosphatidylinositol 3-Kinase and c-src in the Spreading Response of Osteoclasts to Colony-Stimulating Factor-1*
A Grey, Y Chen, I Paliwal, K Carlberg, K Insogna
Endocrinology 2000
Bone Resorption by Osteoclasts
SL Teitelbaum
Science 2000
A novel inhibitor of the tyrosine kinase Src suppresses phosphorylation of its major cellular substrates and reduces bone resorption in vitro and in rodent models in vivo
M Missbach, M Jeschke, J Feyen, K Müller, M Glatt, J Green, M Šuša
Bone 1999
Cell biology of the osteoclast
GD Roodman
Experimental Hematology 1999
Tumor Necrosis Factor-α Mediates Orthopedic Implant Osteolysis
KD Merkel, JM Erdmann, KP McHugh, Y Abu-Amer, FP Ross, SL Teitelbaum
The American Journal of Pathology 1999
Expression and Regulation of RAB3 Proteins in Osteoclasts and Their Precursors
Y Abu-Amer, SL Teitelbaum, JC Chappel, P Schlesinger, FP Ross
Journal of Bone and Mineral Research 1999
Tumor necrosis factor-alpha mediates orthopedic implant osteolysis
KD Merkel, JM Erdmann, KP McHugh, Y Abu-Amer, FP Ross, SL Teitelbaum
The American Journal of Pathology 1999
Osteopontin-deficient mice are resistant to ovariectomy-induced bone resorption
H Yoshitake, SR Rittling, DT Denhardt, M Noda
Proceedings of the National Academy of Sciences 1999
The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts
TL Burgess, Y Qian, S Kaufman, BD Ring, G Van, C Capparelli, M Kelley, H Hsu, WJ Boyle, CR Dunstan, S Hu, DL Lacey
The Journal of Cell Biology 1999
TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling
MA Lomaga, WC Yeh, I Sarosi, GS Duncan, C Furlonger, A Ho, S Morony, C Capparelli, G Van, S Kaufman, A der Heiden, A Itie, A Wakeham, W Khoo, T Sasaki, Z Cao, JM Penninger, CJ Paige, DL Lacey, CR Dunstan, WJ Boyle, DV Goeddel, TW Mak
Genes & development 1999
Gene expression during osteoclast-like cell formation induced by antifusion regulatory protein-1/CD98/4F2 monoclonal antibodies (MAbs): c-src is selectively induced by anti-FRP-1 MAb
Y Higuchi, M Ito, M Tajima, S Higuchi, N Miyamoto, M Nishio, M Kawano, S Kusagawa, M Tsurudome, A Sudo, K Katou, A Uchida, Y Ito
Bone 1999
TRANCE, a TNF Family Member, Activates Akt/PKB through a Signaling Complex Involving TRAF6 and c-Src
BR Wong, D Besser, N Kim, JR Arron, M Vologodskaia, H Hanafusa, Y Choi
Molecular Cell 1999
Structure-activity relationships of a novel class of Src SH2 inhibitors
JL Buchanan, CB Vu, TJ Merry, EG Corpuz, SG Pradeepan, UN Mani, M Yang, HR Plake, VM Varkhedkar, BA Lynch, IA MacNeil, KA Loiacono, CL Tiong, DA Holt
Bioorganic & Medicinal Chemistry Letters 1999
Structure-based design and synthesis of a novel class of Src SH2 inhibitors
JL Buchanan, RS Bohacek, GP Luke, M Hatada, X Lu, DC Dalgarno, SS Narula, R Yuan, DA Holt
Bioorganic & Medicinal Chemistry Letters 1999
Implications for Src Kinases in Hematopoiesis: Signal Transduction Therapeutics
S Sinha, SJ Corey
Journal of Hematotherapy & Stem Cell Research 1999
Mechanisms of Osteoclast Dysfunction in Human Osteopetrosis: Abnormal Osteoclastogenesis and Lack of Osteoclast-Specific Adhesion Structures
A Teti, S Migliaccio, A Taranta, S Bernardini, GD Rossi, M Luciani, M Iacobini, LD Felice, R Boldrini, C Bosman, A Corsi, P Bianco
Journal of Bone and Mineral Research 1999
Human malignant osteopetrosis: Pathophysiology, management and the role of bone marrow transplantation
A Fasth, O Porras
Pediatric Transplantation 1999
Advances in Amino Acid Mimetics and Peptidomimetics
TJ Tucker, RC Isaacs
Advances in Amino Acid Mimetics and Peptidomimetics Volume 2 1999
Extensive Clear Zone and Defective Ruffled Border Formation in Osteoclasts of Osteopetrotic (ia/ia) Rats: Implications for Secretory Function
FP Reinholt, K Hultenby, D Heinegård, SC Marks, M Norgård, G Anderson
Experimental Cell Research 1999
C-terminal Src Kinase Associates with Ligand-stimulated Insulin-like Growth Factor-I Receptor
C Arbet-Engels, S Tartare-Deckert, W Eckhart
The Journal of biological chemistry 1999
Bisphosphonates in Clinical Oncology
B Thürlimann
1999
Src-Related Protein Tyrosine Kinases in Hematopoiesis
SJ Corey, SM Anderson
Blood 1999
Cloning and identification of human Sca as a novel inhibitor of osteoclast formation and bone resorption
SJ Choi, RD Devlin, C Menaa, H Chung, GD Roodman, SV Reddy
Journal of Clinical Investigation 1998
PYK2 in osteoclasts is an adhesion kinase, localized in the sealing zone, activated by ligation of alpha(v)beta3 integrin, and phosphorylated by src kinase
LT Duong, PT Lakkakorpi, I Nakamura, M Machwate, RM Nagy, GA Rodan
Journal of Clinical Investigation 1998
Expression of Src Family Kinases and Their Putative Substrates in the Human Preosteoclastic Cell Line FLG 29.1
M Jeschke, ML Brandi, M Šuša
Journal of Bone and Mineral Research 1998
Cloning and identification of human Sca as a novel inhibitor of osteoclast formation and bone resorption
SJ Choi, RD Devlin, C Menaa, H Chung, GD Roodman, SV Reddy
Journal of Clinical Investigation 1998
A beta 1 integrin signaling pathway involving Src-family kinases, Cbl and PI-3 kinase is required for macrophage spreading and migration
F Meng, CA Lowell
The EMBO Journal 1998
Bone resorption caused by three periodontal pathogens in vivo in mice is mediated in part by prostaglandin
Y Zubery, CR Dunstan, BM Story, L Kesavalu, JL Ebersole, SC Holt, BF Boyce
Infection and immunity 1998
Age-resolving osteopetrosis: a rat model implicating microphthalmia and the related transcription factor TFE3
KN Weilbaecher, CL Hershey, CM Takemoto, MA Horstmann, TJ Hemesath, AH Tashjian, DE Fisher
Journal of Experimental Medicine 1998
SRC64 Regulates the Localization of a Tec-Family Kinase Required for Drosophila Ring Canal Growth
DJ Guarnieri, GS Dodson, MA Simon
Molecular Cell 1998
WISKOTT-ALDRICH SYNDROME: CURRENT RESEARCH CONCEPTS
PM Brickell, DR Katz, AJ Thrasher
British Journal of Haematology 1998
Protein tyrosine kinases: Structure, substrate specificity, and drug discovery
FA Al-Obeidi, JJ Wu, KS Lam
Biopolymers 1998
Colony Stimulating Factor-1-Induced Osteoclast Spreading Depends on Substrate and Requires the Vitronectin Receptor and the c-src Proto-Oncogene
A Teti, A Taranta, S Migliaccio, A Degiorgi, E Santandrea, I Villanova, T Faraggiana, M Chellaiah, KA Hruska
Journal of Bone and Mineral Research 1998
Commitment and differentiation of stem cells to the osteoclast lineage
SI Hayashi, T Yamane, A Miyamoto, H Hemmi, H Tagaya, Y Tanio, H Kanda, H Yamazaki, T Kunisada
Biochemistry and Cell Biology 1998
Age-resolving Osteopetrosis: A Rat Model Implicating Microphthalmia and the Related Transcription Factor TFE3
KN Weilbaecher, CL Hershey, CM Takemoto, MA Horstmann, TJ Hemesath, AH Tashjian, DE Fisher
Journal of Experimental Medicine 1998
Advances in Organ Biology
AJ Liedtke
Advances in Organ Biology 1998
Sphingomyelinase and ceramide inhibit formation of F-actin ring in and bone resorption by rabbit mature osteoclasts
H Takeda, K Ozaki, H Yasuda, M Ishida, S Kitano, S Hanazawa
FEBS Letters 1998
Metabolic Bone Disease and Clinically Related Disorders
FR Singer, SM Krane
Metabolic Bone Disease and Clinically Related Disorders 1998
The protein tyrosine kinase p60c-Src is not implicated in the pathogenesis of the human autosomal recessive form of osteopetrosis: A study of 13 children
F Bernard, JL Casanova, G Cournot, N Jabado, J Peake, S Jauliac, A Fischer, C Hivroz
The Journal of Pediatrics 1998
Targeted disruption of the biglycan gene leads to an osteoporosis-like phenotype in mice
T Xu, P Bianco, LW Fisher, G Longenecker, E Smith, S Goldstein, J Bonadio, A Boskey, AM Heegaard, B Sommer, K Satomura, P Dominguez, C Zhao, AB Kulkarni, PG Robey, MF Young
Nature Genetics 1998
Histomorphometric Evidence for Echistatin Inhibition of Bone Resorption in Mice with Secondary Hyperparathyroidism
P Masarachia, M Yamamoto, CT Leu, G Rodan, L Duong
Endocrinology 1998
c-Src Is Required for Stimulation of Gelsolin-associated Phosphatidylinositol 3-Kinase
M Chellaiah, C Fitzgerald, U Alvarez, K Hruska
The Journal of biological chemistry 1998
Tumor Necrosis Factor-α Activation of Nuclear Transcription Factor-κB in Marrow Macrophages Is Mediated by c-Src Tyrosine Phosphorylation of IκBα
Y Abu-Amer, FP Ross, KP McHugh, A Livolsi, JF Peyron, SL Teitelbaum
The Journal of biological chemistry 1998
Tyrosine Phosphorylation of p130 Cas Is Involved in Actin Organization in Osteoclasts
I Nakamura, E Jimi, LT Duong, T Sasaki, N Takahashi, GA Rodan, T Suda
The Journal of biological chemistry 1998
Novel Approaches to Treatment of Osteoporosis
RG Russell, TM Skerry, U Kollenkirchen
1998
Bone Resorption Caused by Three Periodontal Pathogens In Vivo in Mice Is Mediated in Part by Prostaglandin
JR McGhee, Y Zubery, CR Dunstan, BM Story, L Kesavalu, JL Ebersole, SC Holt, BF Boyce
Infection and immunity 1998
Src64 is required for ovarian ring canal morphogenesis during Drosophila oogenesis
GS Dodson, DJ Guarnieri, MA Simon
Development (Cambridge, England) 1998
Lipopolysaccharide-stimulated osteoclastogenesis is mediated by tumor necrosis factor via its P55 receptor
Y Abu-Amer, FP Ross, J Edwards, SL Teitelbaum
Journal of Clinical Investigation 1997
Colony-stimulating factor-1 induces cytoskeletal reorganization and c-src-dependent tyrosine phosphorylation of selected cellular proteins in rodent osteoclasts
KL Insogna, M Sahni, AB Grey, S Tanaka, WC Horne, L Neff, M Mitnick, JB Levy, R Baron
Journal of Clinical Investigation 1997
Osteoporosis
DL Glaser, FS Kaplan
Spine 1997
Overview of bisphosphonates
MJ Rogers, DJ Watts, RG Russell
Cancer 1997
Regulation of Osteoclast Function
T Suda, I Nakamura, E Jimi, N Takahashi
Journal of Bone and Mineral Research 1997
The localization of CD44 and moesin in osteoclasts after calcitonin administration in mouse tibiae
H Nakamura, M Yamada, M Fukae, H Ozawa
Journal of Bone and Mineral Metabolism 1997
Substrate recognition by osteoclast precursors induces C-src/microtubule association
Y Abu-Amer, FP Ross, P Schlesinger, MM Tondravi, SL Teitelbaum
The Journal of Cell Biology 1997
Requirement for NF-kappaB in osteoclast and B-cell development
G Franzoso, L Carlson, L Xing, L Poljak, EW Shores, KD Brown, A Leonardi, T Tran, BF Boyce, U Siebenlist
Genes & development 1997
Rescue of osteoclast function by transgenic expression of kinase-deficient Src in src-/- mutant mice
PL Schwartzberg, L Xing, O Hoffmann, CA Lowell, L Garrett, BF Boyce, HE Varmus
Genes & development 1997
Integrins and osteoclast polarization
SL Teitelbaum, H Tanaka, H Mimura, M Inoue, M Shima, A Shioi, M Chiba, S Kitazawa, FP Ross
Osteoporosis International 1997
CELLULAR FUNCTIONS REGULATED BY SRC FAMILY KINASES
SM Thomas, JS Brugge
Annual Review of Cell and Developmental Biology 1997
Osteoclast precursors in bone marrow and peritoneal cavity
SI Hayashi, A Miyamoto, T Yamane, H Kataoka, M Ogawa, S Sugawara, S Nishikawa, SI Nishikawa, T Sudo, H Yamazaki, T Kunisada
Journal of Cellular Physiology 1997
Role of c-Src in cellular events associated with colony-stimulating factor-1-induced spreading in osteoclasts
K Insogna, S Tanaka, L Neff, W Horne, J Levy, R Baron
Molecular Reproduction and Development 1997
Phosphatidylinositol-3 kinase is involved in ruffled border formation in osteoclasts
I Nakamura, T Sasaki, S Tanaka, N Takahashi, E Jimi, T Kurokawa, Y Kita, S Ihara, T Suda, Y Fukui
Journal of Cellular Physiology 1997
Alendronate inhibition of protein-tyrosine-phosphatase-meg1
EE Opas, SJ Rutledge, E Golub, A Stern, Z Zimoio, GA Rodan, A Schmidt
Biochemical Pharmacology 1997
1,25-dihydroxyvitamin D3 regulates pp60c-src activity and expression of a pp60c-src activating phosphatase
J Chappel, F P Ross, Y Abu-Amer, A Shaw, S L Teitelbaum
Journal of Cellular Biochemistry 1997
Design, Synthesis, and Cocrystal Structure of a Nonpeptide Src SH2 Domain Ligand
MS Plummer, DR Holland, A Shahripour, EA Lunney, JH Fergus, JS Marks, P McConnell, WT Mueller, TK Sawyer
Journal of Medicinal Chemistry 1997
Bisphosphonates: mechanisms of action
GA Rodan, HA Fleisch
Journal of Clinical Investigation 1996
Molecular aspects of osteoclast function
TJ Hall, TJ Chambers
Inflammation Research 1996
Development and characterization of a porcine model to study osteoclast differentiation and activity
RJ Galvin, P Bryan, JW Horn, MK Rippy, JE Thomas
Bone 1996
Variable effects of tyrosine kinase inhibitors on avian osteoclastic activity and reduction of bone loss in ovariectomized rats
HC Blair, SE Jordan, TG Peterson, S Barnes
Journal of Cellular Biochemistry 1996
Wiskott–Aldrich syndrome protein (WASp) is a binding partner for c-Src family protein-tyrosine kinases
S Banin, O Truong, DR Katz, MD Waterfield, PM Brickell, I Gout
Current Biology 1996
Regulatory mechanisms of osteoclast differentiation and function
GR Mundy
Journal of Bone and Mineral Metabolism 1996
Immunolocalization of CD44 and the ERM family in bone cells of mouse tibiae
H Nakamura, H Ozawa
Journal of Bone and Mineral Research 1996
Human blood-mobilized hematopoietic precursors differentiate into osteoclasts in the absence of stromal cells
A Matayoshi, C Brown, JF DiPersio, J Haug, Y Abu-Amer, H Liapis, R Kuestner, R Pacifici
Proceedings of the National Academy of Sciences 1996
Bacterially induced bone destruction: mechanisms and misconceptions
SP Nair, S Meghji, M Wilson, K Reddi, P White, B Henderson
Infection and immunity 1996
Protein-tyrosine phosphatase activity regulates osteoclast formation and function: inhibition by alendronate
A Schmidt, SJ Rutledge, N Endo, EE Opas, H Tanaka, G Wesolowski, CT Leu, Z Huang, C Ramachandaran, SB Rodan, GA Rodan
Proceedings of the National Academy of Sciences 1996
Molecular cloning and expression of a unique rabbit osteoclastic phosphotyrosyl phosphatase
LW Wu, DJ Baylink, KH Lau
Biochemical Journal 1996
Cytoskeletal changes in osteoclasts during the resorption cycle
PT Lakkakorpi, HK Väänänen
Microscopy Research and Technique 1996
Activation of human pp60c-src
JD Bjorge, TJ O'Connor, DJ Fujita
Biochemistry and Cell Biology 1996
Regulation, substrates and functions of src
MT Brown, JA Cooper
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1996
Mechanism of osteoclast-mediated bone resorption
HK Väänänen, J Salo, P Lehenkari
Journal of Bone and Mineral Metabolism 1996
Animal models of osteopetrosis: the impact of recent molecular developments on novel strategies for the therapeutic intervention
SN Popoff, GB Schneider
Molecular Medicine Today 1996
Identification of a Novel 135-kDa Grb2-binding Protein in Osteoclasts
M Sahni, XM Zhou, L Bakiri, J Schlessinger, R Baron, JB Levy
The Journal of biological chemistry 1996
Stimulation of Mouse Osteopontin Promoter by v-Src Is Mediated by a CCAAT Box-binding Factor
K Tezuka, DT Denhardt, GA Rodan, S Harada
The Journal of biological chemistry 1996
Increased bone formation in osteocalcin-deficient mice
P Ducy, C Desbois, B Boyce, G Pinero, B Story, C Dunstan, E Smith, J Bonadio, S Goldstein, C Gundberg, A Bradley, G Karsenty
Nature 1996
c-Cbl is downstream of c-Src in a signalling pathway necessary for bone resorption
S Tanaka, M Amling, L Neff, A Peyman, E Uhlmann, JB Levy, R Baron
Nature 1996
The Molecular Biology of Paget’s Disease
PT Sharpe
1996
Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo
DE Hughes, KR Wright, HL Uy, A Sasaki, T Yoneda, DG Roodman, GR Mundy, BF Boyce
Journal of Bone and Mineral Research 1995
The heterogeneity of the osteopetroses reflects the diversity of cellular influences during skeletal development
SN Popoff, SC Marks
Bone 1995
Differentiation dependent expression of tensin and cortactin in chicken osteoclasts
K Hiura, SS Lim, SP Little, S Lin, M Sato
Cell Motility and the Cytoskeleton 1995
Possible involvement of focal adhesion kinase, p125FAK, in osteoclastic bone resorption
S Tanaka, N Takahashi, N Udagawa, H Murakami, I Nakamura, T Kurokawa, T Suda
Journal of Cellular Biochemistry 1995
Porphyromonas gingivalis fimbria-stimulated bone resorption in vitro is inhibited by a tyrosine kinase inhibitor
S Hanazawa, Y Kawata, Y Murakami, K Naganuma, S Amano, Y Miyata, S Kitano
Infection and immunity 1995
Engagement of the Osteoclast Integrin ?v?3by Osteopontin Stimulates Phosphatidylinositol 3-Hydroxyl Kinase Activityb
KA Hruska, F Rolnick, M Huskey, U Alvarez, D Cheresh
Annals of the New York Academy of Sciences 1995
Signalling by the p60c-src family of protein—tyrosine kinases
P Kefalas, TR Brown, PM Brickell
The International Journal of Biochemistry & Cell Biology 1995
Targeting the mouse genome: a compendium of knockouts (part III)
EP Brandon, RL Idzerda, GS McKnight
Current Biology 1995
Wortmannin, a specific inhibitor of phosphatidylinositol-3 kinase, blocks osteoclastic bone resorption
I Nakamura, N Takahashi, T Sasaki, S Tanaka, N Udagawa, H Murakami, K Kimura, Y Kabuyama, T Kurokawa, T Suda, Y Fukui
FEBS Letters 1995
Wortmannin, a potent inhibitor of phosphatidylinositol 3-kinase, inhibits osteoclastic bone resorption in vitro
TJ Hall, H Jeker, M Schaueblin
Calcified Tissue International 1995
Mycotrienins
D Feuerbach, R Waelchli, T Fehr, JH Feyen
The Journal of biological chemistry 1995
Association of the amino-terminal half of c-Src with focal adhesions alters their properties and is regulated by phosphorylation of tyrosine 527
KB Kaplan, KB Bibbins, JR Swedlow, M Arnaud, DO Morgan, HE Varmus
The EMBO Journal 1994
A novel monoclonal antibody recognizing a unique antigen of rat osteoclasts induced by the calcified matrices
K Hata, A Akamine, T Kukita, T Iijima, A Kukita, K Kurisu
Histochemistry 1994
Soluble alpha v beta 3-integrin ligands raise [Ca2+]i in rat osteoclasts and mouse-derived osteoclast-like cells
Z Zimolo, G Wesolowski, H Tanaka, JL Hyman, JR Hoyer, GA Rodan
American journal of physiology. Cell physiology 1994
The effects of bisphosphonates on the resorption cycle of isolated osteoclasts
K Selander, P Lehenkari, HK Vnnen
Calcified Tissue International 1994
Metastatic Bone Disease
IJ Diel, M Kaufmann, G Bastert
1994
PEPTIDES AND GROWTH REGULATORY FACTORS IN BONE
GR Mundy
Rheumatic diseases clinics of North America 1994
Identification of a hormonally regulated protein tyrosine phosphatase associated with bone and testicular differentiation
LJ Mauro, EA Olmsted, BM Skrobacz, RJ Mourey, AR Davis, JE Dixon
The Journal of biological chemistry 1994
Herbimycin A, a pp60c-src tyrosine kinase inhibitor, inhibits osteoclastic bone resorption in vitro and hypercalcemia in vivo
T Yoneda, C Lowe, CH Lee, G Gutierrez, M Niewolna, PJ Williams, E Izbicka, Y Uehara, GR Mundy
Journal of Clinical Investigation 1993
Cytokines and growth factors in the regulation of bone remodeling
GR Mundy
Journal of Bone and Mineral Research 1993
Role of cytokines in bone resorption
GR Mundy
Journal of Cellular Biochemistry 1993
Osteopetrosis in Src-deficient mice is due to an autonomous defect of osteoclasts
C Lowe, T Yoneda, BF Boyce, H Chen, GR Mundy, P Soriano
Proceedings of the National Academy of Sciences 1993
Histomorphometric and immunocytochemical studies of src-related osteopetrosis
BF Boyce, H Chen, P Soriano, GR Mundy
Bone 1993
Accumulation of high level of pp60c-srcN is an early event during GM3-antibody mediated differentiation of neuro-2a neuroblastoma cells
M Chakraborty, GM Anderson, A Chakraborty, D Chatterjee
Brain Research 1993
Cellular and Molecular Biology of Bone
M Demay, H Jüppner, AB Abou-Samra, G Segre, H Kronenberg
Cellular and Molecular Biology of Bone 1993
Lysosomes
G Weissmann
New England Journal of Medicine 1965

← Previous 1 2 … 16 17 18 19 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 26 patents
65 readers on Mendeley
See more details